<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Alzheimers Res Ther</journal-id><journal-id journal-id-type="iso-abbrev">Alzheimers Res Ther</journal-id><journal-title-group><journal-title>Alzheimer's Research &#x00026; Therapy</journal-title></journal-title-group><issn pub-type="epub">1758-9193</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6854691</article-id><article-id pub-id-type="publisher-id">542</article-id><article-id pub-id-type="doi">10.1186/s13195-019-0542-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Retinal thinning of inner sub-layers is associated with cortical atrophy in a mouse model of Alzheimer&#x02019;s disease: a longitudinal multimodal in vivo study</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Chiquita</surname><given-names>Samuel</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Campos</surname><given-names>Elisa J.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Castelhano</surname><given-names>Jo&#x000e3;o</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Ribeiro</surname><given-names>M&#x000e1;rio</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Sereno</surname><given-names>Jos&#x000e9;</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Moreira</surname><given-names>Paula I.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Castelo-Branco</surname><given-names>Miguel</given-names></name><address><phone>+351239488514</phone><email>mcbranco@fmed.uc.pt</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0477-1641</contrib-id><name><surname>Ambr&#x000f3;sio</surname><given-names>Ant&#x000f3;nio Francisco</given-names></name><address><phone>+351239480093</phone><email>afambrosio@fmed.uc.pt</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9511 4342</institution-id><institution-id institution-id-type="GRID">grid.8051.c</institution-id><institution>Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, </institution><institution>University of Coimbra, </institution></institution-wrap>3000-548 Coimbra, Portugal </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9511 4342</institution-id><institution-id institution-id-type="GRID">grid.8051.c</institution-id><institution>CNC.IBILI Consortium, </institution><institution>University of Coimbra, </institution></institution-wrap>3004-504 Coimbra, Portugal </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9511 4342</institution-id><institution-id institution-id-type="GRID">grid.8051.c</institution-id><institution>Coimbra Institute for Biomedical Imaging and Translational Research (CIBIT), </institution><institution>University of Coimbra, </institution></institution-wrap>3000-548 Coimbra, Portugal </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9511 4342</institution-id><institution-id institution-id-type="GRID">grid.8051.c</institution-id><institution>Institute for Nuclear Sciences Applied to Health (ICNAS), </institution><institution>University of Coimbra, </institution></institution-wrap>3000-548 Coimbra, Portugal </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9511 4342</institution-id><institution-id institution-id-type="GRID">grid.8051.c</institution-id><institution>Center for Neuroscience and Cell Biology (CNC), </institution><institution>University of Coimbra, </institution></institution-wrap>3004-517 Coimbra, Portugal </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9511 4342</institution-id><institution-id institution-id-type="GRID">grid.8051.c</institution-id><institution>Institute of Physiology, Faculty of Medicine, </institution><institution>University of Coimbra, </institution></institution-wrap>3004-517 Coimbra, Portugal </aff></contrib-group><pub-date pub-type="epub"><day>13</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>11</volume><elocation-id>90</elocation-id><history><date date-type="received"><day>20</day><month>5</month><year>2019</year></date><date date-type="accepted"><day>22</day><month>9</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">It has been claimed that the retina can be used as a window to study brain disorders. However, concerning Alzheimer&#x02019;s disease (AD), it still remains controversial whether changes occurring in the brain and retina are associated. We aim to understand when changes start appearing in the retina and brain, how changes progress, and if they are correlated.</p></sec><sec><title>Methods</title><p id="Par2">We carried out a unique longitudinal study, at 4, 8, 12, and 16&#x02009;months of age, in a triple transgenic mouse model of AD (3&#x000d7;Tg-AD), which mimics pathological and neurobehavioral features of AD, as we have already shown. Retinal structure and physiology were evaluated in vivo using optical coherence tomography and electroretinography. Brain visual cortex structure was evaluated in vivo using magnetic resonance imaging.</p></sec><sec><title>Results</title><p id="Par3">The retinal thickness of 3&#x000d7;Tg-AD decreased, at all time points, except for the outer nuclear layer, where the opposite alteration was observed. Amplitudes in scotopic and photopic responses were increased throughout the study. Similarly, higher amplitude and lower phase values were observed in the photopic flicker response. No differences were found in the activity of retinal ganglion cells. Visual cortex gray matter volume was significantly reduced.</p></sec><sec><title>Conclusions</title><p id="Par4">Our results show that this animal model shows similar neural changes in the retina and brain visual cortex, i.e., retinal and brain thinning. Moreover, since similar changes occur in the retina and brain visual cortex, these observations support the possibility of using the eye as an additional tool (noninvasive) for early AD diagnosis and therapeutic monitoring.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Alzheimer&#x02019;s disease</kwd><kwd>3&#x000d7;Tg-AD mouse model</kwd><kwd>Retina</kwd><kwd>Brain</kwd></kwd-group><funding-group><award-group><funding-source><institution>Santa Casa</institution></funding-source><award-id>Mantero Belard Award 2015 (MB-1049-2015)</award-id><principal-award-recipient><name><surname>Ambr&#x000f3;sio</surname><given-names>Ant&#x000f3;nio Francisco</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Funda&#x000e7;&#x000e3;o para a Ci&#x000ea;ncia e a Tecnologia</institution></funding-source><award-id>SFRH/BD/52045/2012</award-id><award-id>SFRH/BPD/93672/2013</award-id><award-id>PEst UID/NEU/04539/2013</award-id><award-id>MEDPERSYST SAICTPAC/0010/2015</award-id><principal-award-recipient><name><surname>Chiquita</surname><given-names>Samuel</given-names></name><name><surname>Campos</surname><given-names>Elisa J.</given-names></name><name><surname>Castelo-Branco</surname><given-names>Miguel</given-names></name><name><surname>Ambr&#x000f3;sio</surname><given-names>Ant&#x000f3;nio Francisco</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001871</institution-id><institution>Funda&#x000e7;&#x000e3;o para a Ci&#x000ea;ncia e a Tecnologia</institution></institution-wrap></funding-source><award-id>PEst UID/NEU/04539/2019</award-id><principal-award-recipient><name><surname>Ambr&#x000f3;sio</surname><given-names>Ant&#x000f3;nio Francisco</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>COMPETE-FEDER </institution></funding-source><award-id>POCI-01-0145-FEDER-007440</award-id><principal-award-recipient><name><surname>Ambr&#x000f3;sio</surname><given-names>Ant&#x000f3;nio Francisco</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>COMPETE-FEDER</institution></funding-source><award-id>POCI-01-0145-FEDER-016428</award-id><principal-award-recipient><name><surname>Castelo-Branco</surname><given-names>Miguel</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Centro 2020 Regional Operational Programme </institution></funding-source><award-id>CENTRO-01-0145-FEDER-000008: BrainHealth 2020</award-id><award-id>CENTRO-01-0145-FEDER-000016:BIGDATIMAGE</award-id><principal-award-recipient><name><surname>Castelo-Branco</surname><given-names>Miguel</given-names></name><name><surname>Ambr&#x000f3;sio</surname><given-names>Ant&#x000f3;nio Francisco</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par29">The concept of &#x0201c;the retina as a window to the brain&#x0201d; has emerged with possible implications in various pathologies, such as Alzheimer&#x02019;s disease (AD), Parkinson&#x02019;s disease and multiple sclerosis [<xref ref-type="bibr" rid="CR1">1</xref>]. In AD, it is still difficult to identify subclinical biomarkers that can predict the subsequent appearance of symptoms [<xref ref-type="bibr" rid="CR2">2</xref>]. Moreover, in order to have a definitive diagnosis of AD, there is the need to identify amyloid &#x003b2; (A&#x003b2;) plaques and neurofibrillary tangles post-mortem [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. To achieve better and earlier treatments for AD, it is crucial to target early diagnosis. Thus, there is an urgent need to identify new biomarkers that can reliably help diagnose early AD onset [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par30">Visual alterations have been detected in AD patients, and those alterations can be associated with structural and functional changes in the retina [<xref ref-type="bibr" rid="CR7">7</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref>]. Retinal imaging and electrophysiology can be used to evaluate structural and functional abnormalities in the retina, a more accessible structure for a potential early AD detection [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. The eye enables to perform noninvasive, inexpensive and in vivo tests, which is often not the case concerning the brain. In particular, optical coherence tomography (OCT) measurements have shown that there is a thinning of the retina in AD patients [<xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR16">16</xref>]. Actually, manifestations in AD, Parkinson&#x02019;s disease and multiple sclerosis have been reported with the aid of OCT quantifications [<xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR21">21</xref>]. Retinal nerve fiber layer (RNFL) thickness reduction has been observed in AD patients [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>]. However, other authors have claimed that there are no differences in RNFL thickness between mild cognitive impairment or AD patients and control groups [<xref ref-type="bibr" rid="CR26">26</xref>&#x02013;<xref ref-type="bibr" rid="CR29">29</xref>]. Further studies in AD patients also showed the reduction of ganglion cell layer (GCL) [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>] and inner plexiform layer (IPL) thickness [<xref ref-type="bibr" rid="CR32">32</xref>&#x02013;<xref ref-type="bibr" rid="CR34">34</xref>], as well as cortical atrophy, namely the decrease in the volume of visual cortex [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Recently, the existence of A&#x003b2; plaques in the retina was reported in several AD animals models [<xref ref-type="bibr" rid="CR14">14</xref>], and in both post-mortem retinas of advanced and early stage AD patients [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>] and, using curcumin-based fundus imaging, in AD patients [<xref ref-type="bibr" rid="CR39">39</xref>].</p><p id="Par31">Aiming to clarify the controversy related with the possible use of the eye as a window to the brain in AD, longitudinal studies with large cohorts need to be carried out. Mouse models of AD offer the possibility of performing longitudinal studies on a much shorter timescale than in AD patients. There are several studies designed to assess retinal structural and functional changes in AD murine models [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR40">40</xref>&#x02013;<xref ref-type="bibr" rid="CR46">46</xref>]. Conversely, there are only a few studies that assess the pathophysiology of AD in animal models simultaneously in the retina and brain, trying to establish possible correlations between these structures [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR47">47</xref>&#x02013;<xref ref-type="bibr" rid="CR51">51</xref>]. These studies assessed only few structural and functional parameters, without expressing the inner sub-layers detail, Therefore, we aimed to get further insight into the pathophysiology of AD and, particularly, to understand if changes in the retina correlate with changes in the visual cortex. To achieve this goal, we performed a unique and novel longitudinal study using the 3&#x000d7;Tg-AD mouse model. We previously showed that 3&#x000d7;Tg-AD mice have recognition memory impairment, early hippocampal structural loss, increased A&#x003b2; and hyperphosphorylated tau, and decreased levels of taurine [<xref ref-type="bibr" rid="CR52">52</xref>]. In the present study, we assessed simultaneously the retinal and visual cortex alterations, in vivo, at four different time points: 4, 8, 12 and 16&#x02009;months of age. This is, thus, an approach much more relevant for clinical setting. Furthermore, the combination of structural and functional changes, either in the retina and brain regions, such as the visual cortex, might be used as biomarker for early AD diagnosis.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Animals</title><p id="Par32">Experiments were performed in male 3&#x000d7;Tg-AD mice harboring three human mutant genes, presenilin-1 (PS1<sub>M146V</sub>), amyloid precursor protein (APP<sub>SWE</sub>) and tau (tau<sub>P301L</sub>), which develop the pathological hallmarks of AD in an age-dependent manner [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>], and in gender- and age-matched WT animals (C57BL6/129S background). The 3&#x000d7;Tg-AD line was originally generated by co-microinjection of human APP<sub>K670M/N671L</sub> and tau<sub>P301L</sub> transgenes, under the control of the Thy 1.2 promoter, into mutant PS1<sub>M146V</sub> knock-in mice [<xref ref-type="bibr" rid="CR54">54</xref>]. Male 3&#x000d7;Tg-AD and WT mice were used to evaluate in vivo structural and/or functional changes in the retina and visual cortex at 4, 8, 12 and 16&#x02009;months of age. The animals were maintained at 22&#x02009;&#x000b1;&#x02009;1&#x02009;&#x000b0;C, 68% relative humidity, in a 12&#x02009;h light/12&#x02009;h dark cycle, with access to water and food ad libitum. All procedures involving animals were approved by the Animal Welfare Committee of the Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra. The animal experimentation was conducted in accordance with the European Community directive guidelines for the use of animals in laboratory (2010/63/EU), transposed into the Portuguese law in 2013 (Decreto-Lei 113/2013), and with the Association for Research in Vision and Ophthalmology (ARVO) statement for animal use.</p></sec><sec id="Sec4"><title>OCT imaging</title><p id="Par33">Retinal structure was evaluated using OCT, which then allowed to perform the segmentation of retinal layers. In order to evaluate in vivo structural changes, a longitudinal study was carried out at 4, 8, 12 and 16&#x02009;months of age using 3&#x000d7;Tg-AD and age-matched WT mice. In vivo OCT line and circular scans were acquired with Phoenix OCT2 together with Phoenix Micron IV retinal imaging microscope (Phoenix Research Laboratories, San Ramon, CA, USA). Retinal thickness was measured using InSight image segmentation software (v.1,&#x000a0;Voxeleron LLC - Image analysis solutions, Chabot Drive, CA, USA) between the inner limiting membrane and the retinal pigment epithelium. For each eye, one OCT scan was performed around the optic nerve head and six scans were performed above and below the optic nerve head (Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S1A). Subsequently, measurements of ganglion cell layer (GCL) plus the inner plexiform layer (IPL), inner nuclear layer (INL) plus outer plexiform layer (OPL), outer nuclear layer (ONL), inner segments (IS) plus outer segments (OS) and total retina thickness were obtained both for 3&#x000d7;Tg-AD and WT animals (Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S1B). Circular and line scan thickness values for each animal are presented as the average value of both eyes. To perform OCT, animals were anesthetized using a combination of ketamine+xylazine 80&#x02009;mg/kg&#x02009;+&#x02009;5&#x02009;mg/kg (Imalgene 1000, Merial, Lyon, France, and Rompum&#x000ae;, Bayer, Leverkusen, Germany, respectively) administered with one intraperitoneal injection. Pupils were dilated using topical tropicamide (1%, Tropicil&#x000ae;, Laborat&#x000f3;rio Edol, Carnaxide, Portugal). The cornea was anesthetized with topical anesthetic eye drops (4&#x02009;mg/ml oxybuprocaine hydrochloride, Anestocil&#x000ae;, Laborat&#x000f3;rio Edol, Carnaxide, Portugal). The cornea was kept hydrated and optically cleared using hydroxypropyl methylcellulose (Methocel&#x02122; 2%, D&#x000e1;vi II Farmac&#x000ea;utica S.A., Barcarena, Portugal), during the whole procedure.</p></sec><sec id="Sec5"><title>Electroretinography</title><p id="Par34">Retinal physiology was evaluated using flash and pattern electroretinography (fERG and PERG, respectively), in which electrical response of retinal cells is measured. PERG allowed for the assessment of the function of retinal ganglion cells (RGCs). Assays were performed at 4, 8, 12, and 16&#x02009;months of age in 3&#x000d7;Tg-AD and age-matched WT mice.</p><sec id="Sec6"><title>Flash electroretinography</title><p id="Par35">After 12&#x02009;h overnight dark adaptation, mice were anesthetized with an intraperitoneal injection of ketamine (80&#x02009;mg/kg) and xylazine (5&#x02009;mg/kg) in 0.1&#x02009;ml saline solution, under dim red light illumination. Pupil was dilated using topical phenylephrine (100&#x02009;mg/ml phenylephrine hydrochloride, Davinefrina, D&#x000e1;vi II Farmac&#x000ea;utica S.A.), and the cornea was locally anesthetized and kept hydrated, as described in the previous section. The body temperature was maintained with a heating pad set to 37&#x02009;&#x000b0;C. ERG recordings were acquired using a RETIport System (Roland Consult Electrophysiological Diagnostic Systems, Brandenburg, Germany), based on a protocol described previously (Rosolen et al., 2005). The gold ring electrode (gold wire 0.25&#x02009;mm, 2.5&#x02009;mm diameter, Roland Consult) was placed at the corneal surface, the reference electrode was placed subcutaneously at the head, and the ground electrode was placed also subcutaneously in the base of the tail. Light stimulation was performed using a Ganzfeld stimulator (Roland Consult). Series of white flashes of seven different light intensities (0.0095 to 9.49&#x02009;cd.s/m<sup>2</sup>) were delivered three times at 0.1 and 1.3&#x02009;Hz for the acquisition of the scotopic and photopic luminance responses, respectively. Photopic adaptation to a white background (25&#x02009;cd/m<sup>2</sup>) was carried out during 16&#x02009;min, and light flashes with intensity of 9.49&#x02009;cd.s/m<sup>2</sup> were applied three times at 1.3&#x02009;Hz, at the onset of light adaptation and at 2, 4, 8, and 16&#x02009;min of light adaptation. For the photopic flicker response, under a white background light (25&#x02009;cd.s/m<sup>2</sup>), white bright flashes (3.00 and 9.49&#x02009;cd.s/m<sup>2</sup>) were delivered ten times at 6.3&#x02009;Hz. ERGs were recorded with a bandwidth of 1&#x02013;300&#x02009;Hz at a sampling rate of 3.4&#x02009;kHz (0.8&#x02009;kHz for flicker test). Measurement of negative <italic>a</italic>-wave,&#x000a0;positive <italic>b</italic>-wave&#x000a0;and&#x000a0;individual oscillatory potentials (OPs) amplitude and&#x000a0;time to peak&#x000a0;values, were made using RETIport software (Roland Consult). Scotopic <italic>a</italic>-wave and <italic>b</italic>-wave amplitudes were obtained for seven light intensities from 0.0095 to 9.49&#x02009;cd.s/m<sup>2</sup>. Four OPs were extracted for six light intensities between 0.030 and 9.49&#x02009;cd.s/m<sup>2</sup>. During photopic adaptation, the <italic>b</italic>-wave amplitude was measured. <italic>b</italic>-wave amplitude photopic luminance responses were measured for 3.00 and 9.49&#x02009;cd.s/m<sup>2</sup>. OFF-line digital filter was applied on the <italic>b</italic>-wave (high-frequency cut-off of 50&#x02009;Hz) and oscillatory potentials (low-frequency cut-off of 60&#x02009;Hz for scotopic ERGs and 55&#x02009;Hz for photopic ERGs). Flicker responses were evaluated by determining the amplitude and phase of the base wave (6.33&#x02009;Hz), first (12.7&#x02009;Hz), and second (19&#x02009;Hz) harmonics with the fast Fourier transform.</p></sec><sec id="Sec7"><title>Pattern electroretinography</title><p id="Par36">Animals were prepared as described in the previous section. Light-adapted PERG recordings were acquired using the RETIport System (Roland Consult). Electrodes were placed in the animal, as described above. Stimuli were dark and light gratings displayed on a monitor whose center was aligned with the projection of the pupil and presented from a short distance (typically, 20&#x02009;cm) to stimulate a large retinal area. Stimuli were displayed for 200 sweeps of contrast reversals with 1&#x02009;Hz temporal frequency, contrast between 95 and 100%. After PERG recording of the right eye, a new electrode was placed on the left eye and the same procedure was followed. RGC activity was evaluated by measuring an initial corneal positive response, referred to as P50, followed by a corneal negative response, referred to as N95. An evaluation of the amplitude of P50/P1 and N95/N2, the time to peak of the major positive and negative deflection was performed. Signals were band pass filtered (1&#x02013;40&#x02009;Hz) and artifact rejection was set at 100&#x02009;&#x003bc;V peak to peak with a sample frequency of 1.136&#x02009;kHz.</p></sec></sec><sec id="Sec8"><title>Magnetic resonance imaging (MRI)</title><p id="Par37">Brain structure was evaluated using magnetic resonance imaging (MRI). Data acquisition was performed at 4, 8, 12, and 16&#x02009;months of age in 3&#x000d7;Tg-AD and age-matched WT mice.</p><sec id="Sec9"><title>Data acquisition</title><p id="Par38">MRI experiments were performed in a BioSpec 9.4&#x02009;T scanner with a standard cross coil setup using a volume coil for excitation (with 86/112&#x02009;mm of inner/outer diameter, respectively) and quadrature mouse surface coil for signal detection (Bruker Biospin, Ettlingen, Germany). Animals were kept anesthetized with isoflurane (1.5%) with 100% O<sub>2</sub> and body temperature and respiration monitoring (SA Instruments SA, Stony Brook, NY, USA). T2-weighted images were acquired in coronal planes using a Rapid Acquisition with Relaxation Enhancement (RARE) sequence with the following parameters: TR&#x02009;=&#x02009;3800&#x02009;ms; TE&#x02009;=&#x02009;33&#x02009;ms; 10 averages; pixel size of 0.078&#x02009;mm&#x02009;&#x000d7;&#x02009;0.078&#x02009;mm and slice thickness of 0.5&#x02009;mm without spacing between slices (total head volume: 256 pixels&#x02009;&#x000d7;&#x02009;256 pixels&#x02009;&#x000d7;&#x02009;34 slices).</p></sec><sec id="Sec10"><title>Data analysis</title><p id="Par39">Voxel-based morphometry (VBM) was performed using the statistical parametric mapping software (SPM, Welcome Department of Cognitive Neurology, London, UK), the SPMMouse toolbox [<xref ref-type="bibr" rid="CR55">55</xref>], and a homemade script involving the following steps: (a) T2-weighted images were corrected for the magnetic field inhomogeneity generated by the surface coil and this was done using intensity curves from T2-weighted images obtained for an homogeneous phantom and acquired with the same coil and system configuration; (b) the rigid body was aligned by registering (affine transformation) the images to the template space; (c) tissue segmentation was carried out by means of the gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF) tissue probability maps as provided in the toolbox; (d) GM images were non-linearly normalized to the template space and were modulated to correct for volume changes that might have occurred during normalization; (e) a binary mask, corresponding to the right visual cortex, was drawn in the template space and placed in each aligned GM image; (f) finally, the GM volume was quantified by multiplying the GM volume in each voxel by the number of voxels. All steps were done using the default settings of the toolbox.</p></sec></sec><sec id="Sec11"><title>Statistical analysis</title><p id="Par40">Statistical analysis was performed using GraphPad Prism Version 6 (GraphPad Software, San Diego, CA, USA) and SPSS 22.0 (SPSS Inc., Chicago, IL, USA). The normality of the data was assessed with D&#x02019;Agostino and Pearson omnibus normality tests. Differences in thickness of retinal layers and in retinal function between groups, at each time point (4, 8, 12, and 16&#x02009;months) were assessed using an analysis of variance (ANOVA) repeated-measures (mixed-effects), where time was assumed as &#x0201c;within-subject&#x0201d; factor, and the experimental group (i.e., 3&#x000d7;Tg-AD and WT mice) was assumed as &#x0201c;between-subject&#x0201d; factor, followed by a post hoc <italic>t</italic>-test. Differences in GM volumes of the visual cortex along time and between groups were assessed using an ANOVA repeated measures (mixed-effects) followed by a Bonferroni post hoc <italic>t</italic>-test. Results were presented as mean&#x02009;&#x000b1;&#x02009;SEM. Statistical significance was considered at *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, and ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001.</p></sec></sec><sec id="Sec12"><title>Results</title><sec id="Sec13"><title>Reduction of retinal thickness of 3&#x000d7;Tg-AD mice</title><p id="Par41">We evaluated, in vivo, whether the retinal structure of 3&#x000d7;Tg-AD mice was affected, using OCT (line and circle scans; Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S1), followed by the segmentation of retinal layers. ANOVA revealed that the total retina thickness was significantly decreased in 3&#x000d7;Tg-AD mice compared to that in WT mice (line scans, <italic>F</italic> (1, 33)&#x02009;=&#x02009;100.2, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; circle scans, <italic>F</italic> (1, 31)&#x02009;=&#x02009;106.0, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a, Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S3A). However, no time effect was observed (line scans, <italic>F</italic> (3, 99)&#x02009;=&#x02009;1.3, <italic>p</italic>&#x02009;=&#x02009;0.270) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a). Furthermore, throughout the study, we observed a significant thinning of GCL+IPL (<italic>F</italic> (2.6, 85.7)&#x02009;=&#x02009;3.4, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) and INL+OPL (<italic>F</italic> (2.2, 72.5)&#x02009;=&#x02009;19.0, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), whereas no time effect was observed on the IS+OS layer thickness (<italic>F</italic> (2.5, 82.8)&#x02009;=&#x02009;0.73, <italic>p</italic>&#x02009;=&#x02009;0.510). The thickness of each retinal layer was consistently significantly lower in 3&#x000d7;Tg-AD mice compared to WT mice (GCL+IPL, <italic>F</italic> (1, 33)&#x02009;=&#x02009;121.8, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; INL+OPL, <italic>F</italic> (1, 33)&#x02009;=&#x02009;22.7, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; IS+OS layer, <italic>F</italic> (1, 33)&#x02009;=&#x02009;105.1, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Particularly, at 16&#x02009;months, the total retinal thickness of WT mice, 192.3&#x02009;&#x003bc;m, decreased to 177.9&#x02009;&#x003bc;m in 3&#x000d7;Tg-AD mice (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a), and the thickness of GGL+IPL decreased from 60.7&#x02009;&#x003bc;m in WT mice to 51.0&#x02009;&#x003bc;m in 3&#x000d7;Tg-AD mice (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b), whereas the IS+OS layer thickness was 39.5&#x02009;&#x003bc;m and 33.1&#x02009;&#x003bc;m in WT and 3&#x000d7;Tg-AD mice, respectively (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>e). However, conversely to the results obtained for the layers described above, a significant increase of ONL thickness (<italic>F</italic> (2.6, 85.1)&#x02009;=&#x02009;8.6, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) was observed, during the study. Also the thickness of ONL of 3&#x000d7;Tg-AD mice was significantly higher (<italic>F</italic> (1, 33)&#x02009;=&#x02009;8.7, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01) in comparison with WT mice (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>d). At 16&#x02009;months, the ONL thickness was 58.8&#x02009;&#x003bc;m and 55.5&#x02009;&#x003bc;m in 3&#x000d7;Tg-AD and WT mice, respectively (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001). Overall, we observed a thinning of total retina, GCL+IPL, INL+OPL, and IS+OS of 3&#x000d7;Tg-AD mice. Conversely, ONL was found to be thicker in this AD animal model.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Thickness of different retinal layers in WT (white bars) and 3&#x000d7;Tg-AD (black bars) mice at 4, 8, 12, and 16&#x02009;months of age, based on in vivo OCT line scans. The thickness of retinal layers was measured using the InSight software. <bold>a</bold> Total retina, <bold>b</bold> GCL+IPL, <bold>c</bold> INL+OPL, <bold>d</bold> ONL, <bold>e</bold> IS+OS. The results are presented as mean&#x02009;&#x000b1;&#x02009;SEM. *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, according to Student&#x02019;s <italic>t</italic> test. <italic>n</italic><sub>WT</sub>: at 4&#x02009;months&#x02009;=&#x02009;21, at 8&#x02009;months&#x02009;=&#x02009;19, at 12&#x02009;months&#x02009;=&#x02009;17, at 16&#x02009;months&#x02009;=&#x02009;17; <italic>n</italic>
<sub>3&#x000d7;Tg-AD</sub>: at 4&#x02009;months&#x02009;=&#x02009;22, at 8&#x02009;months&#x02009;=&#x02009;22, at 12&#x02009;months&#x02009;=&#x02009;22, at 16&#x02009;months&#x02009;=&#x02009;22</p></caption><graphic xlink:href="13195_2019_542_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec14"><title>Alterations in the retinal physiological scotopic responses of 3&#x000d7;Tg-AD animals</title><p id="Par42">We used fERG to explore the functional integrity of specific retinal cell types in both WT and 3&#x000d7;Tg-AD mice. Regarding the scotopic response, the retina is stimulated with low-intensity light flashes to induce rod activation. The function of photoreceptors and downstream retinal cells can then be examined. Photoreceptors (mainly rods) are the cells contributing to <italic>a</italic>-wave, whereas the <italic>b</italic>-wave is widely believed to reflect mainly the activation of bipolar cells. OPs are thought to reflect cell activity in the inner retina, mainly amacrine cells [<xref ref-type="bibr" rid="CR56">56</xref>].</p><p id="Par43">The results obtained from the analysis of these electroretinograms showed that, overall, 3&#x000d7;Tg-AD mice had significantly higher scotopic <italic>a</italic>-wave amplitude than age-matched WT mice (<italic>F</italic> (1, 30)&#x02009;=&#x02009;10.6, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01), particularly, at 4 and 12&#x02009;months (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a). ANOVA further determined significant differences in scotopic <italic>a</italic>-wave amplitude during the study (<italic>F</italic> (2.0, 62.8)&#x02009;=&#x02009;4.0, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). Our results also showed that 3&#x000d7;Tg-AD mice present lower time to peak values in comparison with age-matched WT animals, mainly at higher luminance (<italic>F</italic> (1, 28)&#x02009;=&#x02009;130.2, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S4). Therefore, we observed a faster response in the <italic>a</italic>-wave of 3&#x000d7;Tg-AD mice. The amplitude of scotopic <italic>b</italic>-wave resulting from rod activation (<italic>b</italic><sub>rod</sub>, <italic>F</italic> (1, 30)&#x02009;=&#x02009;33.2, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) and from rod and cone activation (<italic>b</italic><sub>mix</sub>, <italic>F</italic> (1, 30)&#x02009;=&#x02009;52.6, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) of 3&#x000d7;Tg-AD mice was significantly higher than age-matched WT mice, regardless of the time point (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b, c, respectively). Actually, clear differences between 3&#x000d7;Tg-AD and age-matched WT mice were observed at 4, 8, 12, and 16&#x02009;months of age, regardless of the luminance (<italic>F</italic> (1, 28)&#x02009;=&#x02009;35.5, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Moreover, we observed a reduction of the <italic>b</italic>-wave amplitude difference between 3&#x000d7;Tg-AD and WT mice, from 4 to 16&#x02009;months of age (<italic>F</italic> (3, 84)&#x02009;=&#x02009;8.6, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S5). We further found a significant reduction of <italic>b</italic><sub>rod</sub> (<italic>F</italic> (1.9, 55.5)&#x02009;=&#x02009;4.5, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) and <italic>b</italic><sub>mix</sub> (<italic>F</italic> (1.9, 56.3)&#x02009;=&#x02009;9.8, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) amplitude, along time.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Retinal function in WT and 3&#x000d7;Tg-AD mice at 4, 8, 12, and 16&#x02009;months of age assessed by fERG, under scotopic conditions. Main component values obtained in response to 0.0095&#x02009;cd.s/m<sup>2</sup> light stimulus (b<sub>rod</sub>) or 9.49&#x02009;cd.s/m<sup>2</sup> light stimulus (<italic>a</italic><sub>mix</sub>, <italic>b</italic><sub>mix</sub>, and OP1) in WT (white bars) and 3&#x000d7;Tg-AD (black bars): <bold>a</bold>
<italic>a</italic><sub>mix</sub> amplitude, <bold>b</bold>
<italic>b</italic><sub>rod</sub> amplitude, <bold>c</bold>
<italic>b</italic><sub>mix</sub> amplitude, <bold>d</bold> OP1 amplitude. The results are presented as mean&#x02009;&#x000b1;&#x02009;SEM. *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, <italic>**p&#x02009;&#x0003c;</italic>&#x000a0;0.01, and <italic>***p&#x02009;&#x0003c;</italic>&#x000a0;0.001 according to Student&#x02019;s <italic>t</italic> test. <italic>n</italic><sub>WT</sub>: at 4&#x02009;months&#x02009;=&#x02009;19, at 8&#x02009;months&#x02009;=&#x02009;19, at 12&#x02009;months&#x02009;=&#x02009;17, at 16&#x02009;months&#x02009;=&#x02009;17; <italic>n</italic><sub>3&#x000d7;Tg-AD</sub>: at 4&#x02009;months&#x02009;=&#x02009;23, at 8&#x02009;months&#x02009;=&#x02009;23, at 12&#x02009;months&#x02009;=&#x02009;22, at 16&#x02009;months&#x02009;=&#x02009;22</p></caption><graphic xlink:href="13195_2019_542_Fig2_HTML" id="MO2"/></fig>
<fig id="Fig3"><label>Fig. 3</label><caption><p>Scotopic <italic>b</italic>-wave amplitude in WT (white circles) and 3<bold>&#x000d7;</bold>Tg-AD (black circles) mice, at <bold>a</bold> 4, <bold>b</bold> 8, <bold>c</bold> 12, and <bold>d</bold> 16&#x02009;months of age. Graphs present the amplitude of the <italic>b</italic>-wave at the indicated luminance conditions. The results are presented as mean&#x02009;&#x000b1;&#x02009;SEM. *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, according to Student&#x02019;s <italic>t</italic> test. <italic>n</italic><sub>WT</sub>: at 4&#x02009;months&#x02009;=&#x02009;19, at 8&#x02009;months&#x02009;=&#x02009;19, at 12&#x02009;months&#x02009;=&#x02009;17, at 16&#x02009;months&#x02009;=&#x02009;17; <italic>n</italic><sub>3<bold>&#x000d7;</bold>Tg-AD</sub>: at 4&#x02009;months&#x02009;=&#x02009;23, at 8&#x02009;months&#x02009;=&#x02009;23, at 12&#x02009;months&#x02009;=&#x02009;22, at 16&#x02009;months&#x02009;=&#x02009;22</p></caption><graphic xlink:href="13195_2019_542_Fig3_HTML" id="MO3"/></fig></p><p id="Par44">The OP1 amplitude values of 3&#x000d7;Tg-AD mice were higher than those of age-matched WT mice, at all time points (<italic>F</italic> (1, 30)&#x02009;=&#x02009;7.3, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). However, statistically significant differences (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01) were observed only at 12&#x02009;months (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>d). A significant decrease throughout the study was further observed (<italic>F</italic> (3, 90)&#x02009;=&#x02009;3.1, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). OP1 time to peak values were also affected. We observed that 3&#x000d7;Tg-AD mice presented faster OP responses (<italic>F</italic> (1, 29)&#x02009;=&#x02009;28.4, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S6). During the study, no significant differences were found (<italic>F</italic> (2.6, 74.8)&#x02009;=&#x02009;2.5, <italic>p</italic>&#x02009;=&#x02009;0.074). No statistically significant interaction time and experimental group was observed in scotopic response. In summary, under scotopic conditions, we found several alterations in <italic>a</italic>-wave, <italic>b</italic>-wave, and OPs of 3&#x000d7;Tg-AD, regarding amplitude and time to peak, denoting clear physiological alterations in the retina of this AD animal model.</p></sec><sec id="Sec15"><title>Increased amplitude of photopic responses of 3&#x000d7;Tg-AD mice</title><p id="Par45">Once fully light-adapted, the retina was stimulated with high-intensity light flashes. Thus, during the photopic response, the function of cone photoreceptors is measured, since the rod response is suppressed [<xref ref-type="bibr" rid="CR56">56</xref>]. The <italic>b</italic>-wave amplitude of 3&#x000d7;Tg-AD mice was significantly higher (<italic>F</italic> (1, 30)&#x02009;=&#x02009;49.5, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) than WT mice. However, no statistically significant differences were observed at 16&#x02009;months (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a). Throughout the study, we observed a statistically significant decrease in the <italic>b</italic>-wave amplitude (<italic>F</italic> (3, 90)&#x02009;=&#x02009;4.0, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01), particularly between 4 (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) and 8 (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01) months vs 16&#x02009;months. The interaction time and experimental group was also found to be statistically significant (<italic>F</italic> (3, 90)&#x02009;=&#x02009;2.8, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). Accordingly, similarly to scotopic conditions, retinal photopic responses were altered in the retina of 3&#x000d7;Tg-AD mice.
<fig id="Fig4"><label>Fig. 4</label><caption><p>Retinal function in WT and 3&#x000d7;Tg-AD mice at 4, 8, 12, and 16&#x02009;months of age, assessed by fERG, under photopic conditions. Main component values obtained in response to 9.49&#x02009;cd.s/m<sup>2</sup> light stimulus in WT (white bars) and 3&#x000d7;Tg-AD (black bars): <bold>a</bold>
<italic>b</italic><sub>cone</sub> amplitude, <bold>b</bold> base wave amplitude. The results are presented as mean&#x02009;&#x000b1;&#x02009;SEM. **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, <italic>***p&#x02009;&#x0003c;</italic>&#x000a0;0.001 according to Student&#x02019;s <italic>t</italic> test. <italic>n</italic><sub>WT</sub>: at 4&#x02009;months&#x02009;=&#x02009;19, at 8&#x02009;months&#x02009;=&#x02009;19, at 12&#x02009;months&#x02009;=&#x02009;17, at 16&#x02009;months&#x02009;=&#x02009;17; <italic>n</italic><sub>3&#x000d7;Tg-AD</sub>: at 4&#x02009;months&#x02009;=&#x02009;23, at 8&#x02009;months&#x02009;=&#x02009;23, at 12&#x02009;months&#x02009;=&#x02009;22, at 16&#x02009;months&#x02009;=&#x02009;22</p></caption><graphic xlink:href="13195_2019_542_Fig4_HTML" id="MO4"/></fig></p></sec><sec id="Sec16"><title>Increased photopic flicker harmonic amplitude of 3&#x000d7;Tg-AD mice</title><p id="Par46">As in the photopic response, in the photopic flicker response the electrical activity is mainly cone-driven. The base wave (<italic>F</italic> (1, 30)&#x02009;=&#x02009;160.0, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), first (<italic>F</italic> (1, 30)&#x02009;=&#x02009;57.0, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), and second (<italic>F</italic> (1, 30)&#x02009;=&#x02009;83.6, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) harmonic amplitudes of 3&#x000d7;Tg-AD mice was significantly higher compared to age-matched WT mice, at all time points (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b and Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a, c, e, g). We also found an overall significant decrease of base wave amplitude values, throughout the different time points (<italic>F</italic> (1.6, 49.1)&#x02009;=&#x02009;14.8, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S7A). The interaction time and experimental group was also found to be statistically significant (<italic>F</italic> (1.6, 49.1)&#x02009;=&#x02009;6.0, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01). The first harmonic amplitude values also decreased over time (<italic>F</italic> (1.5, 45.5)&#x02009;=&#x02009;14.6, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S7C). The interaction time and experimental group was statistically significant as well (<italic>F</italic> (1.5, 45.5)&#x02009;=&#x02009;4.0, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). The second harmonic amplitude values significantly decrease overtime (<italic>F</italic> (1.5, 46.1)&#x02009;=&#x02009;11.8, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S7E). Regarding the interaction time and experimental group, statistically significant differences were found (<italic>F</italic> (1.5, 46.1)&#x02009;=&#x02009;6.3, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01).
<fig id="Fig5"><label>Fig. 5</label><caption><p>Photopic flicker retinal response in WT (white bars) and 3&#x000d7;Tg-AD (black bars) mice at <bold>a</bold>, <bold>b</bold> 4, <bold>c</bold>, <bold>d</bold> 8, <bold>e</bold>, <bold>f</bold> 12, and <bold>g</bold>, <bold>h</bold> 16&#x02009;months of age. The responses were recorded in response to 9.49&#x02009;cd.s/m<sup>2</sup> light stimulus. The amplitude and phase of the signal were evaluated after fast Fourier transform. The results are presented as mean&#x02009;&#x000b1;&#x02009;SEM. **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, according to Student&#x02019;s <italic>t</italic> test. <italic>n</italic><sub>WT</sub>: at 4&#x02009;months&#x02009;=&#x02009;19, at 8&#x02009;months&#x02009;=&#x02009;19, at 12&#x02009;months&#x02009;=&#x02009;17, at 16&#x02009;months&#x02009;=&#x02009;17; <italic>n</italic><sub>3&#x000d7;Tg-AD</sub>: at 4&#x02009;months&#x02009;=&#x02009;23, at 8&#x02009;months&#x02009;=&#x02009;23, at 12&#x02009;months&#x02009;=&#x02009;22, at 16&#x02009;months&#x02009;=&#x02009;22</p></caption><graphic xlink:href="13195_2019_542_Fig5_HTML" id="MO5"/></fig></p><p id="Par47">Moreover, 3&#x000d7;Tg-AD animals tend to follow the input base wave frequency (6.33&#x02009;Hz) more effectively than WT mice leading to a difference in phase responses (<italic>F</italic> (1, 30)&#x02009;=&#x02009;100.8, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>b, d, f, h and Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S7B). In the first harmonic phase, a similar result was obtained, meaning that 3&#x000d7;Tg-AD mice still had a faster response at first harmonic frequency (12.7&#x02009;Hz) than WT mice (<italic>F</italic> (1, 30)&#x02009;=&#x02009;21.9, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref> b, d, f, h and Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S7D). Conversely, WT mice were found to have a faster response at second harmonic frequency (<italic>F</italic> (1, 30)&#x02009;=&#x02009;80.8, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) (19&#x02009;Hz, Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>b, d, f, h and Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>, Figure S7F). No statistically significant time effect was observed in the flicker responses, nor any interaction time and experimental group. Overall, we observed higher amplitude and lower phase values in the photopic flicker response of 3&#x000d7;Tg-AD.</p></sec><sec id="Sec17"><title>Similar PERG responses of 3&#x000d7;Tg-AD and WT mice</title><p id="Par48">Electrophysiological assessment of RGC function was made using PERG. Regarding amplitude, no statistically significant differences were observed between 3&#x000d7;Tg-AD and age-matched WT mice (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). In particular, no statistically significant differences were found between both groups in P1 and N2 implicit time and amplitude, at all time points (data not shown).
<fig id="Fig6"><label>Fig. 6</label><caption><p>RGC function in WT and 3&#x000d7;Tg-AD mice at 4, 8, 12, and 16&#x02009;months of age, assessed by PERG. PERG amplitude obtained in WT (white bars) and 3&#x000d7;Tg-AD (black bars). The results are presented as mean&#x02009;&#x000b1;&#x02009;SEM. No statistically significant differences were obtained, according to Student&#x02019;s <italic>t</italic> test. <italic>n</italic><sub>WT</sub>: at 4&#x02009;months&#x02009;=&#x02009;19, at 8&#x02009;months&#x02009;=&#x02009;19, at 12&#x02009;months&#x02009;=&#x02009;17, at 16&#x02009;months&#x02009;=&#x02009;17; <italic>n</italic><sub>3&#x000d7;Tg-AD</sub>: at 4&#x02009;months&#x02009;=&#x02009;23, at 8&#x02009;months&#x02009;=&#x02009;23, at 12&#x02009;months&#x02009;=&#x02009;22, at 16&#x02009;months&#x02009;=&#x02009;22</p></caption><graphic xlink:href="13195_2019_542_Fig6_HTML" id="MO6"/></fig></p></sec><sec id="Sec18"><title>Volume reduction of visual cortex gray matter of 3&#x000d7;Tg-AD mice</title><p id="Par49">We acquired whole-brain anatomical MRI data to study potential alterations in the GM volume of 3&#x000d7;Tg-AD mice relatively to age-matched WT mice, at different time points (4, 8, 12, and 16&#x02009;months of age). A whole-brain analysis revealed a significant age-dependent reduction of the GM volume between both groups (<italic>F</italic> (1, 8)&#x02009;=&#x02009;71.0, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001). Furthermore, an analysis focused on the visual cortex, as a region-of-interest (ROI) (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>a), also showed that the GM volume of the 3&#x000d7;Tg-AD mice was significantly reduced compared to the age-matched WT mice (<italic>F</italic> (1, 8)&#x02009;=&#x02009;105.0, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), at all time points (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>b). VBM analysis showed a significant decrease in 3&#x000d7;Tg-AD animals in comparison to age-matched WT mice, at all time points (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>b).
<fig id="Fig7"><label>Fig. 7</label><caption><p>Gray matter volume analysis in the visual cortex. <bold>a</bold> Region of interest used in the assessment of the visual cortex volume overlaid on a mean T2-weighted image. <bold>b</bold> GM volume in the visual cortex of WT (white circles) and 3&#x000d7;Tg-AD (black circles) mice measured by VBM analysis. Results are presented as mean&#x02009;&#x000b1;&#x02009;SEM. The significance of the alterations in GM volumes of the visual cortex along time and between groups was assessed by an ANOVA repeated measures (mixed-effects) followed by a Bonferroni post hoc test. **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 and ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001. <italic>n</italic><sub>WT</sub>&#x02009;=&#x02009;6, <italic>n</italic><sub>3&#x000d7;Tg-AD</sub>&#x02009;=&#x02009;7</p></caption><graphic xlink:href="13195_2019_542_Fig7_HTML" id="MO7"/></fig></p></sec><sec id="Sec19"><title>Retinal thickness changes and physiological responses are correlated with visual cortex gray matter volume</title><p id="Par50">In order to further elucidate the correlation between the alterations in the retina and visual cortex, we performed a correlation analysis between the retinal thickness and photopic flicker response with the GM volume in the visual cortex. The Spearman correlation test showed a positive correlation between total retinal thickness and GM volume (retina line scan: <italic>r</italic><sub>S</sub>&#x02009;=&#x02009;0.657, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; retina circle scan: <italic>r</italic><sub>S</sub>&#x02009;=&#x02009;0.728, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S8A). Additionally, we performed the same analysis to evaluate the correlation between photopic flicker response amplitude and GM volume in the visual cortex. We found a significant negative correlation between photopic flicker base amplitude and GM volume in the visual cortex (<italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.790, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S8B). Moreover, the correlation of retinal thickness, namely for both line and circle scans in the GCL+IPL and the photopic flicker response amplitude was found to be negative, at all time points (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Correlations of photopic flicker (base) amplitude with retina and retinal cell layers thickness</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>4&#x02009;months</th><th>8&#x02009;months</th><th>12&#x02009;months</th><th>16&#x02009;months</th></tr></thead><tbody><tr><td>Total retina (line scan)</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.2401&#x02009;ns</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.6554***</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.6920***</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.6822***</td></tr><tr><td>Total retina (circle scan)</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.5258**</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.6276***</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.7620***</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.7157***</td></tr><tr><td>GCL+IPL (line scan)</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.3833*</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.6554***</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.6317***</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.6763***</td></tr><tr><td>GCL+IPL (circle scan)</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.4070*</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.6970***</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.6937***</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.7108***</td></tr><tr><td>INL+OPL (line scan)</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.2372&#x02009;ns</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.5290**</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.5396**</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.3801*</td></tr><tr><td>INL+OPL (circle scan)</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.0345&#x02009;ns</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.3232&#x02009;ns</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.5885***</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.4265*</td></tr><tr><td>ONL (line scan)</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.0108&#x02009;ns</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.0792&#x02009;ns</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;0.5521**</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;0.4663**</td></tr><tr><td>ONL (circle scan)</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;0.0296&#x02009;ns</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.0016&#x02009;ns</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;0.3765*</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;0.5493**</td></tr><tr><td>IS+OS (line scan)</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.1039&#x02009;ns</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.7188***</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.7614***</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.6525***</td></tr><tr><td>IS+OS (circle scan)</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.3707*</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.6885***</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.8194***</td><td><italic>r</italic><sub>S</sub>&#x02009;=&#x02009;&#x02212;&#x02009;0.7771***</td></tr></tbody></table><table-wrap-foot><p>(<italic>n</italic><sub>circle scan</sub>&#x02009;=&#x02009;30, <italic>n</italic><sub>line scan</sub>&#x02009;=&#x02009;32). <italic>r</italic><sub>S</sub> quantifies Spearman correlation. <italic>ns</italic> not significant, *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, and ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.00</p></table-wrap-foot></table-wrap></p><p id="Par51">Results are summarized in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Summary of the main retinal (structural and functional) and brain (visual cortex) changes in 3&#x000d7;Tg-AD mice</p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="8">Retinal structure (layer thickness)</td></tr><tr><td>Total retina</td><td colspan="2">GCL+IPL</td><td colspan="2">INL+OPL</td><td>ONL</td><td colspan="2">IS+OS</td></tr><tr><td>&#x02193;</td><td colspan="2">&#x02193;</td><td colspan="2">&#x02193;</td><td>&#x02191;</td><td colspan="2">&#x02193;</td></tr><tr><td colspan="8">Retinal function</td></tr><tr><td colspan="8">ERG</td></tr><tr><td colspan="4">Scotopic</td><td>Photopic</td><td colspan="3">Flicker</td></tr><tr><td><italic>a</italic><sub>mix</sub></td><td><italic>b</italic><sub>rod</sub></td><td><italic>b</italic><sub>mix</sub></td><td>OP1</td><td><italic>b</italic><sub>cone</sub></td><td>Base wave</td><td>First harmonic</td><td>Second harmonic</td></tr><tr><td>&#x02191; Amplitude</td><td>&#x02191; Amplitude</td><td>&#x02191; Amplitude</td><td>&#x02191; Amplitude</td><td>&#x02191; Amplitude</td><td>&#x02191; Amplitude</td><td>&#x02191; Amplitude</td><td>&#x02191; Amplitude</td></tr><tr><td>&#x02193; Time to peak</td><td/><td/><td>&#x02193; Time to peak</td><td/><td>&#x02193; Phase</td><td>&#x02193; Phase</td><td>&#x02191; Phase</td></tr><tr><td colspan="8">PERG</td></tr><tr><td colspan="8">No changes</td></tr><tr><td colspan="8">Brain (visual cortex)</td></tr><tr><td colspan="8">&#x02193; Gray matter volume</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec20"><title>Discussion</title><p id="Par52">Recently, in a longitudinal study (4, 8, 12, and 16&#x02009;months of age) using a mouse model of AD, 3&#x000d7;Tg-AD, we reported that this model presents, since the early time points, (i) recognition memory impairment, (ii) increased levels of A&#x003b2; and hyperphosphorylated tau in the hippocampus, (iii) decreased hippocampal volume, and (iv) loss of taurine, which is an important endogenous neuroprotector. We showed that hippocampal volumetry and neurospectroscopy can be early valuable biomarkers, which parallel neurobehavioral deficits, thus providing an in vivo multimodal validation of the 3&#x000d7;Tg-AD mouse as an early disease model [<xref ref-type="bibr" rid="CR52">52</xref>].</p><p id="Par53">In the present study, we also used 3&#x000d7;Tg-AD&#x000a0;mice to assess if the retina can be a window or a mirror of the brain. Again, we performed a longitudinal multimodal in vivo assessment at four different time points (4, 8, 12, and 16&#x02009;months of age), both in the retina and brain. Here, correlations between changes in the retina and brain were performed, based on different physiological and structural approaches in association with MRI. This study also represents not only a completely new approach in animal models to tackle the potential links between retinal and brain changes in the context of AD pathology, but also gives new clues about the pathology and confirms some findings that have been already observed in humans. In the present study, only male mice were used. Recent evidences support the importance of using a balanced population of male and female subjects due to their distinct biochemical, physiological, and structural features in several organs including the brain [<xref ref-type="bibr" rid="CR57">57</xref>&#x02013;<xref ref-type="bibr" rid="CR59">59</xref>]. It was reported that 3&#x000d7;Tg-AD male mice present a delayed and milder phenotype compared to female counterparts [<xref ref-type="bibr" rid="CR60">60</xref>]. However, we recently showed that 3&#x000d7;Tg-AD male mice present pathological and neurobehavioral features of AD, with early-onset recognition memory loss and reduction of hippocampal volume [<xref ref-type="bibr" rid="CR52">52</xref>]. Other studies also demonstrated that male mice present AD features [<xref ref-type="bibr" rid="CR61">61</xref>&#x02013;<xref ref-type="bibr" rid="CR63">63</xref>]. Therefore, 3&#x000d7;Tg-AD male mice remain a valuable experimental model. Concerning the animal model, we further add that mice here used were dark eyes. Eventual differences in mice with dark eyes vs albino mice may be interesting to address in future studies.</p><p id="Par54">Several studies in AD patients, in which retinal thickness was evaluated by OCT, have reported a thinning in the retina [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. Here, we replicated this finding in an animal model, suggesting that OCT may be useful for an early diagnosis of AD and also for the evaluation of the response to treatment in such preclinical models. Therefore, our work does corroborate the notion that AD animal models can be used to assess retinal changes and the impact of neurodegeneration [<xref ref-type="bibr" rid="CR5">5</xref>]. From the best of our knowledge, the present study described, for the first time, the retinal structural and functional changes in 3&#x000d7;Tg-AD animal model. At 4&#x02009;months of age, we observed the thinning of GCL+IPL and of total retina both for circle and line scans, in 3&#x000d7;Tg-AD mice. We also detected the thinning of INL+OPL in OCT line scan acquisitions. These observations suggest that the first signs of retinal impairment in AD start at the innermost layers. With this observation, we cannot discard the possibility that transsynaptic degeneration, from the brain to the retina, may occur. Another possibility is that some changes start occurring in the retina, even before or at least at the same time they start occurring in the brain, although this could not be ascertained. From 8&#x02009;months onwards, we observed the thinning of total retina, GCL+IPL, INL+OPL, and IS+OS of 3&#x000d7;Tg-AD mice. The thinning observed in the inner retina, earlier, at 4&#x02009;months, seemed to spread to almost every analyzed retinal layer. This might be due to secondary degeneration, a phenomenon in which synapses and neurons in the neighborhood of originally affected neurons are also affected. The retinal thinning here observed, even at early time points, is an important finding that corroborates previous results obtained in humans, in which OCT results clearly show that there is retinal thinning in AD patients [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. Despite the generalized thinning of several layers of the retina, there was also an increase in the thickness of the ONL of 3&#x000d7;Tg-AD mice compared to age-matched WT mice. The thickening of ONL is not easy to explain, but we cannot exclude that it might have a developmental cause.</p><p id="Par55">The aim of this research work was to perform a longitudinal in vivo study, using the same animals for the different experimental techniques utilized in each time point. We did not aim to go deeper in the structural changes of the retina and the cortex. We believe that a longitudinal in vivo study has much more relevance for the clinical setting. Moreover, OCT is the technique widely used in clinical evaluation to assess the retina and, in particular, retinal layer thickness. In the context of our study, having very small changes in retinal thickness, histological examination would not definitely be a good approach. Actually, it would be unlikely to detect significant changes using histology. Histological analysis also requires the use of different animals in each time point, which would not be feasible in a longitudinal study. Moreover, it would be impossible to obtain slices exactly in the same region of the retina whereas, by OCT, we were able to analyze the same region of the retina. Also, tissue collection and preparation for histological analysis affects retinal structure, and therefore, the thickness measured would not be as reliable. The same applies to the brain. For instance, we evaluated the volume of the visual cortex in vivo, by MRI, and this is much more reliable than calculating the volume based on histological analysis of the brain.</p><p id="Par56">Regarding retinal electrophysiology, scotopic and photopic <italic>b</italic>-wave amplitudes of 3&#x000d7;Tg-AD and WT mice were significantly different at various time points. We observed alterations in <italic>b</italic>-wave amplitude of 3&#x000d7;Tg-AD mice at 4, 8, 12, and 16&#x02009;months of age, which suggests the existence of physiological modifications in bipolar cells. The increased amplitude values observed in fERG responses, originated from the outer retina, are consistent with the increased ONL thickness that we found. Moreover, the scotopic time to peak in the <italic>a</italic>-wave and OP1 was shorter in 3&#x000d7;Tg-AD mice. Abnormal scotopic <italic>b</italic>-wave implicit time and decreased <italic>a</italic>-wave amplitude have been also reported in 3&#x000d7;Tg-AD mice [<xref ref-type="bibr" rid="CR41">41</xref>]. Furthermore, higher scotopic and photopic <italic>b</italic>-wave amplitudes were previously observed in a mouse model of Down syndrome, in which specific changes in layer thickness were also found [<xref ref-type="bibr" rid="CR66">66</xref>]. In fact, A&#x003b2; deposition has been detected both in AD and Down syndrome patients [<xref ref-type="bibr" rid="CR67">67</xref>]. In Down syndrome patients, the neurodegenerative processes associated with AD are also expressed. Moreover, APP gene is located at chromosome 21, and Down syndrome patients have an extra copy of this chromosome, thus leading to the development of early onset dementia with AD characteristics [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. This may entail that there is a common phenotype in the retina between AD and Down syndrome patients.</p><p id="Par57">Early differences in the ERG response between 3&#x000d7;Tg-AD and WT were observed at the photoreceptor level. In this study, WT animals were chosen according to the genetic background from which 3&#x000d7;Tg-AD mice were generated. It seems that the introduction of human genes that have been associated with AD had an opposite effect to what was expected, if one assumes that the effects of this genetic manipulation impact only on neurodegeneration. However, if developmental effects are also present, as suggested by the increased thickness of ONL, then this might explain increased fERG responses in 3&#x000d7;Tg-AD mice. In general, we observed that fERG signal amplitude, which mainly originates from the outer retina, was higher in 3&#x000d7;Tg-AD mice than in WT mice. However, regarding the inner retinal responses from RGC evaluated by PERG, we did not observe any statistically significant difference between both groups. In previous studies in humans, results obtained with PERG recordings are contradictory. Actually, some studies show abnormal pattern electroretinograms and visual evoked potentials in AD patients [<xref ref-type="bibr" rid="CR70">70</xref>&#x02013;<xref ref-type="bibr" rid="CR73">73</xref>], whereas others report normal retinal function [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. In PERG recordings, P1 is driven by ON pathway while N2 is driven by OFF pathway [<xref ref-type="bibr" rid="CR76">76</xref>]. We did not observe statistically significant differences in P1 and N2 parameters between 3&#x000d7;Tg-AD and WT mice meaning that RGC function is not significantly impaired in this AD animal model.</p><p id="Par58">Since both structural and functional changes were observed in the retina, at all time points, the possible causal links (early neurodegenerative or neurodevelopmental) on structure and function remain somehow elusive. In order to better understand the retinal physiological changes in this AD animal model, it would be essential to perform either multielectrode array or patch clamp recordings, which would enable to determine more precisely the changes in retinal response properties to a given light stimulus. Visual evoked potential recordings would enable to determine if visual information transmitted from the retina to the brain is impaired.</p><p id="Par59">Previous studies have been published reporting retinal molecular and cellular changes in 3&#x000d7;Tg-AD mice. Profound alterations in retinal tau, including abnormal accumulation, phosphorylation, and missorting were already described in 3&#x000d7;Tg-AD mice, at 3&#x02009;months of age [<xref ref-type="bibr" rid="CR77">77</xref>]. These pathological changes are likely to cause substantial retinal neuron dysfunction and subsequent death. The presence of A&#x003b2; plaques, tau tangles, neurodegeneration, and astrogliosis in the retinal ganglion cell layer was described in 3&#x000d7;Tg-AD mice, at 1&#x02013;5&#x02009;months of age. An anti-inflammatory phenotype of retinal microglial cells, at 1&#x02013;5&#x02009;months, which then evolves to a pro-inflammatory phenotype, at 12&#x02013;18&#x02009;months, was also described [<xref ref-type="bibr" rid="CR78">78</xref>]. Several proteins related to oxidative stress, light-dependent processes (e.g., Sag), synaptic functions, metabolism, and energy production in retina were found to be dysregulated in 3&#x000d7;Tg-AD mice, at 2, 4, and 6&#x02009;months of age [<xref ref-type="bibr" rid="CR79">79</xref>]. It is therefore clear that there are several molecular and cellular alterations in the retina of 3&#x000d7;Tg-AD, even at early time points, which can contribute to functional alterations that we observed. However, it is difficult to identify a particular molecular or cellular alteration that is responsible for a particular electrophysiological alteration.</p><p id="Par60">Our results also suggest that there is a positive correlation between retinal thickness and GM volume of the visual cortex, while ERG flicker amplitude is negatively correlated with retinal and cortical structural measurements. However, it is quite difficult to identify the biological basis for these nonlinear (Spearman) correlations and, for example, why changes occurring in the visual cortex could contribute for the thinning or thickening of the retina. In fact, there may be several causes, such as developmental impacts or other indirect effects, that could lead to these correlations. In our opinion, similar pathophysiological mechanisms may occur in the brain and retina, since both structures are part of the CNS. However, what is happening in the visual cortex does not necessarily affect, at least directly, the retina. These associations further suggest that enhanced ERG responses may actually reflect a retinal impairment, as also suggested by Laguna and colleagues [<xref ref-type="bibr" rid="CR59">59</xref>]. Accordingly, we show that retinal structural and functional changes are associated with visual cortex alterations, thus having potential impact on early AD diagnosis.</p></sec><sec id="Sec21"><title>Conclusions</title><p id="Par61">In this longitudinal in vivo study, the 3&#x000d7;Tg-AD mouse model allowed the identification of structural and neurophysiological alterations in the retina, as well as changes in gray matter volume in the visual cortex. These retinocortical alterations showed an early onset and remained persistent over time. Some of these changes appear to be of neurodegenerative nature, as expressed by retinal and brain thinning. Since the retina is an optically accessible part of the brain, OCT may become a feasible, noninvasive, low-cost method and an additional tool for preclinical research in AD. In addition, the 3&#x000d7;Tg-AD mouse model may be used as a potential tool for preclinical studies in which retinal structural and functional changes could be correlated with brain impairments detected by neuroimaging, which may be quite useful for preclinical drug trials. The results emerging from the present research assume particular importance because they enable the establishment of a model in which retinal manifestations of AD are observed at an early time point. Moreover, our results emphasize the possibility of retinal biomarker assessment in AD.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec22"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13195_2019_542_MOESM1_ESM.docx"><caption><p><bold>Additional file 1: </bold><bold>Figure S1.</bold> OCT scan acquisition. <bold>Figure S2.</bold> Retinal layers visualized by OCT. <bold>Figure S3.</bold> Thickness of different retinal layers in WT and 3&#x000d7;Tg-AD mice at 4, 8, 12 and 16 months of age, based on in vivo OCT circle scans. <bold>Figure S4.</bold> Scotopic <italic>a</italic>-wave time to peak in WT and 3&#x000d7;Tg-AD mice, at 4, 8, 12 and 16 months of age, as response to several light stimuli. <bold>Figure S5.</bold> Linear regression fit to scotopic <italic>b</italic>-wave amplitude at 0.0095 cd.s/m<sup>2</sup> and 9.49 cd.s/m<sup>2</sup> in WT and 3&#x000d7;Tg-AD mice. <bold>Figure S6.</bold> OP1 time to peak values at 4, 8, 12 and 16 months of age, based on fERG analysis. <bold>Figure S7.</bold> Linear regression fit to base wave, first harmonic and second harmonic amplitudes and phases in WT and 3&#x000d7;Tg-AD mice. <bold>Figure S8.</bold> Spearman correlation between total retinal thickness and grey matter volume of the visual cortex, and photopic flicker response amplitude and grey matter volume of the visual cortex.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>3&#x000d7;Tg-AD</term><def><p id="Par5">Triple transgenic mouse model of Alzheimer&#x02019;s disease</p></def></def-item><def-item><term>AD</term><def><p id="Par6">Alzheimer&#x02019;s disease</p></def></def-item><def-item><term>A&#x003b2;</term><def><p id="Par8">Amyloid beta</p></def></def-item><def-item><term>CSF</term><def><p id="Par9">Cerebrospinal fluid</p></def></def-item><def-item><term>ERG</term><def><p id="Par10">Electroretinography</p></def></def-item><def-item><term>fERG</term><def><p id="Par11">Flash electroretinography</p></def></def-item><def-item><term>GCL</term><def><p id="Par12">Ganglion cell layer</p></def></def-item><def-item><term>GM</term><def><p id="Par13">Gray matter</p></def></def-item><def-item><term>INL</term><def><p id="Par14">Inner nuclear layer</p></def></def-item><def-item><term>IPL</term><def><p id="Par15">Inner plexiform layer</p></def></def-item><def-item><term>IS</term><def><p id="Par16">Inner segment</p></def></def-item><def-item><term>MRI</term><def><p id="Par17">Magnetic resonance imaging</p></def></def-item><def-item><term>OCT</term><def><p id="Par18">Optical coherence tomography</p></def></def-item><def-item><term>ONL</term><def><p id="Par20">Outer nuclear layer</p></def></def-item><def-item><term>OP</term><def><p id="Par21">Oscillatory potentials</p></def></def-item><def-item><term>OPL</term><def><p id="Par22">Outer plexiform layer</p></def></def-item><def-item><term>OS</term><def><p id="Par23">Outer segment</p></def></def-item><def-item><term>PERG</term><def><p id="Par24">Pattern electroretinography</p></def></def-item><def-item><term>RGC</term><def><p id="Par25">Retinal ganglion cell</p></def></def-item><def-item><term>RNFL</term><def><p id="Par26">Retinal nerve fiber layer</p></def></def-item><def-item><term>WM</term><def><p id="Par27">White matter</p></def></def-item><def-item><term>WT</term><def><p id="Par28">Wild type</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Samuel Chiquita, Elisa J. Campos and Jo&#x000e3;o Castelhano contributed equally to this work</p></fn><fn><p>Miguel Castelo-Branco and Ant&#x000f3;nio Francisco Ambr&#x000f3;sio contributed equally to this work, as senior authors</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s13195-019-0542-8.</p></sec><ack><title>Acknowledgements</title><p>We do thank Ot&#x000ed;lia C. d&#x02019;Almeida, (Laboratory for Biostatistics and Medical Informatics, Faculty of Medicine of the University of Coimbra) for statistical analysis counseling.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>SC did the data acquisition, data analysis, and writing of the original draft. EJC did the data analysis, writing, review, and editing. JC did the data analysis and writing of the original draft. MR did the data analysis and writing of the original draft. JS did the data acquisition. PIM did the conceptualization, writing, review, and editing. MCB did the conceptualization, data analysis, funding acquisition, project administration, resources, supervision, writing, review, and editing. AFA did the conceptualization, data analysis, funding acquisition, project administration, resources, supervision, writing, review, and editing. All authors read and approved the submitted version.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by the Santa Casa Mantero Belard Award 2015 (MB-1049-2015), FCT (SFRH/BD/52045/2012, SFRH/BPD/93672/2013, PEst UID/NEU/04539/2013 and UID/NEU/04539/2019, and MEDPERSYST SAICTPAC/0010/2015), COMPETE-FEDER (POCI-01-0145-FEDER-007440 and POCI-01-0145-FEDER-016428), and Centro 2020 Regional Operational Programme (CENTRO-01-0145-FEDER-000008: BrainHealth 2020 and CENTRO-01-0145-FEDER-000016:BIGDATIMAGE).</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All data generated or analyzed during this study are included in this published article and its additional files.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par62">All procedures involving animals were approved by the Animal Welfare Committee of the Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra. The animal experimentation was conducted in accordance with the European Community directive guidelines for the use of animals in laboratory (2010/63/EU), transposed into the Portuguese law in 2013 (Decreto-Lei 113/2013), and with the Association for Research in Vision and Ophthalmology (ARVO) statement for animal use.</p></notes><notes><title>Consent for publication</title><p id="Par63">Not applicable.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par64">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>London</surname><given-names>A</given-names></name><name><surname>Benhar</surname><given-names>I</given-names></name><name><surname>Schwartz</surname><given-names>M</given-names></name></person-group><article-title>The retina as a window to the brain&#x02014;from eye research to CNS disorders</article-title><source>Nat Rev Neurol</source><year>2013</year><volume>9</volume><issue>1</issue><fpage>44</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2012.227</pub-id><?supplied-pmid 23165340?><pub-id pub-id-type="pmid">23165340</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sperling</surname><given-names>RA</given-names></name><name><surname>Aisen</surname><given-names>PS</given-names></name><name><surname>Beckett</surname><given-names>LA</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Craft</surname><given-names>S</given-names></name><name><surname>Fagan</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Toward defining the preclinical stages of Alzheimer&#x02019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x02019;s Association workgroups on diagnostic guidelines for Alzheimer's disease</article-title><source>Alzheimers Dement</source><year>2011</year><volume>7</volume><issue>3</issue><fpage>280</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1016/j.jalz.2011.03.003</pub-id><?supplied-pmid 21514248?><pub-id pub-id-type="pmid">21514248</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jack</surname><given-names>CR</given-names></name><name><surname>Knopman</surname><given-names>DS</given-names></name><name><surname>Jagust</surname><given-names>WJ</given-names></name><name><surname>Petersen</surname><given-names>RC</given-names></name><name><surname>Weiner</surname><given-names>MW</given-names></name><name><surname>Aisen</surname><given-names>PS</given-names></name><etal/></person-group><article-title>Tracking pathophysiological processes in Alzheimer&#x02019;s disease: an updated hypothetical model of dynamic biomarkers</article-title><source>Lancet Neurol</source><year>2013</year><volume>12</volume><issue>2</issue><fpage>207</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(12)70291-0</pub-id><?supplied-pmid 23332364?><pub-id pub-id-type="pmid">23332364</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutphen</surname><given-names>CL</given-names></name><name><surname>Fagan</surname><given-names>AM</given-names></name><name><surname>Holtzman</surname><given-names>DM</given-names></name></person-group><article-title>Progress update: fluid and imaging biomarkers in Alzheimer&#x02019;s disease</article-title><source>Biol Psychiatry</source><year>2014</year><volume>75</volume><issue>7</issue><fpage>520</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2013.07.031</pub-id><?supplied-pmid 24012326?><pub-id pub-id-type="pmid">24012326</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>JK</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Vingrys</surname><given-names>AJ</given-names></name><name><surname>Chinnery</surname><given-names>HR</given-names></name><name><surname>Li</surname><given-names>Q-X</given-names></name><name><surname>Bui</surname><given-names>BV</given-names></name><etal/></person-group><article-title>Age-related changes in retinal structure and function in a mouse model of Alzheimer&#x02019;s disease</article-title><source>Invest Ophthalmol Vis Sci</source><year>2016</year><volume>57</volume><issue>12</issue><fpage>613</fpage></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frost</surname><given-names>S</given-names></name><name><surname>Martins</surname><given-names>RN</given-names></name><name><surname>Kanagasingam</surname><given-names>Y</given-names></name></person-group><article-title>Ocular biomarkers for early detection of Alzheimer's disease</article-title><source>J Alzheimers Dis</source><year>2010</year><volume>22</volume><issue>1</issue><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.3233/JAD-2010-100819</pub-id><?supplied-pmid 20847434?><pub-id pub-id-type="pmid">20847434</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iseri</surname><given-names>PK</given-names></name><name><surname>Altinas</surname><given-names>&#x000d6;</given-names></name><name><surname>Tokay</surname><given-names>T</given-names></name><name><surname>Y&#x000fc;ksel</surname><given-names>N</given-names></name></person-group><article-title>Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease</article-title><source>J Neuroophthalmol</source><year>2006</year><volume>26</volume><issue>1</issue><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1097/01.wno.0000204645.56873.26</pub-id><?supplied-pmid 16518161?><pub-id pub-id-type="pmid">16518161</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Ming</surname><given-names>B</given-names></name><name><surname>Jia</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><etal/></person-group><article-title>Retinal nerve fiber layer structure abnormalities in early Alzheimer&#x02019;s disease: evidence in optical coherence tomography</article-title><source>Neurosci Lett</source><year>2010</year><volume>480</volume><issue>1</issue><fpage>69</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2010.06.006</pub-id><?supplied-pmid 20609426?><pub-id pub-id-type="pmid">20609426</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satue</surname><given-names>M</given-names></name><name><surname>Obis</surname><given-names>J</given-names></name><name><surname>Rodrigo</surname><given-names>MJ</given-names></name><name><surname>Otin</surname><given-names>S</given-names></name><name><surname>Fuertes</surname><given-names>MI</given-names></name><name><surname>Vilades</surname><given-names>E</given-names></name><etal/></person-group><article-title>Optical coherence tomography as a biomarker for diagnosis, progression, and prognosis of neurodegenerative diseases</article-title><source>J Ophthalmol</source><year>2016</year><volume>2016</volume><fpage>8503859</fpage><?supplied-pmid 27840739?><pub-id pub-id-type="pmid">27840739</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parisi</surname><given-names>V</given-names></name><name><surname>Restuccia</surname><given-names>R</given-names></name><name><surname>Fattapposta</surname><given-names>F</given-names></name><name><surname>Mina</surname><given-names>C</given-names></name><name><surname>Bucci</surname><given-names>MG</given-names></name><name><surname>Pierelli</surname><given-names>F</given-names></name></person-group><article-title>Morphological and functional retinal impairment in Alzheimer's disease patients</article-title><source>Clin Neurophysiol</source><year>2001</year><volume>112</volume><issue>10</issue><fpage>1860</fpage><lpage>1867</lpage><pub-id pub-id-type="doi">10.1016/S1388-2457(01)00620-4</pub-id><?supplied-pmid 11595144?><pub-id pub-id-type="pmid">11595144</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parisi</surname><given-names>Vincenzo</given-names></name></person-group><article-title>Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer&#x02019;s disease</article-title><source>Seminars in Ophthalmology</source><year>2003</year><volume>18</volume><issue>2</issue><fpage>50</fpage><lpage>57</lpage><?supplied-pmid 14566623?><pub-id pub-id-type="pmid">14566623</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>LY</given-names></name><name><surname>Lowe</surname><given-names>J</given-names></name><name><surname>Ardiles</surname><given-names>A</given-names></name><name><surname>Lim</surname><given-names>J</given-names></name><name><surname>Grey</surname><given-names>AC</given-names></name><name><surname>Robertson</surname><given-names>K</given-names></name><etal/></person-group><article-title>Alzheimer&#x02019;s disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers</article-title><source>Alzheimers Dement</source><year>2014</year><volume>10</volume><issue>2</issue><fpage>251</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1016/j.jalz.2013.06.004</pub-id><?supplied-pmid 24011928?><pub-id pub-id-type="pmid">24011928</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzekov</surname><given-names>R</given-names></name><name><surname>Mullan</surname><given-names>M</given-names></name></person-group><article-title>Vision function abnormalities in Alzheimer disease</article-title><source>Surv Ophthalmol</source><year>2014</year><volume>59</volume><issue>4</issue><fpage>414</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/j.survophthal.2013.10.002</pub-id><?supplied-pmid 24309127?><pub-id pub-id-type="pmid">24309127</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>NJ</given-names></name><name><surname>Koronyo</surname><given-names>Y</given-names></name><name><surname>Black</surname><given-names>KL</given-names></name><name><surname>Koronyo-Hamaoui</surname><given-names>M</given-names></name></person-group><article-title>Ocular indicators of Alzheimer&#x02019;s: exploring disease in the retina</article-title><source>Acta Neuropathol</source><year>2016</year><volume>132</volume><issue>6</issue><fpage>767</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1007/s00401-016-1613-6</pub-id><?supplied-pmid 27645291?><pub-id pub-id-type="pmid">27645291</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javaid</surname><given-names>FZ</given-names></name><name><surname>Brenton</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Cordeiro</surname><given-names>MF</given-names></name></person-group><article-title>Visual and ocular manifestations of Alzheimer&#x02019;s disease and their use as biomarkers for diagnosis and progression</article-title><source>Front Neurol</source><year>2016</year><volume>7</volume><fpage>55</fpage><pub-id pub-id-type="doi">10.3389/fneur.2016.00055</pub-id><?supplied-pmid 27148157?><pub-id pub-id-type="pmid">27148157</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doustar</surname><given-names>J</given-names></name><name><surname>Torbati</surname><given-names>T</given-names></name><name><surname>Black</surname><given-names>KL</given-names></name><name><surname>Koronyo</surname><given-names>Y</given-names></name><name><surname>Koronyo-Hamaoui</surname><given-names>M</given-names></name></person-group><article-title>Optical coherence tomography in Alzheimer&#x02019;s disease and other neurodegenerative diseases</article-title><source>Front Neurol</source><year>2017</year><volume>8</volume><fpage>701</fpage><pub-id pub-id-type="doi">10.3389/fneur.2017.00701</pub-id><?supplied-pmid 29312125?><pub-id pub-id-type="pmid">29312125</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frohman</surname><given-names>EM</given-names></name><name><surname>Fujimoto</surname><given-names>JG</given-names></name><name><surname>Frohman</surname><given-names>TC</given-names></name><name><surname>Calabresi</surname><given-names>PA</given-names></name><name><surname>Cutter</surname><given-names>G</given-names></name><name><surname>Balcer</surname><given-names>LJ</given-names></name></person-group><article-title>Optical coherence tomography: a window into the mechanisms of multiple sclerosis</article-title><source>Nat Rev Neurol</source><year>2008</year><volume>4</volume><issue>12</issue><fpage>664</fpage><pub-id pub-id-type="doi">10.1038/ncpneuro0950</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marziani</surname><given-names>E</given-names></name><name><surname>Pomati</surname><given-names>S</given-names></name><name><surname>Ramolfo</surname><given-names>P</given-names></name><name><surname>Cigada</surname><given-names>M</given-names></name><name><surname>Giani</surname><given-names>A</given-names></name><name><surname>Mariani</surname><given-names>C</given-names></name><etal/></person-group><article-title>Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography</article-title><source>Invest Ophthalmol Vis Sci</source><year>2013</year><volume>54</volume><issue>9</issue><fpage>5953</fpage><lpage>5958</lpage><pub-id pub-id-type="doi">10.1167/iovs.13-12046</pub-id><?supplied-pmid 23920375?><pub-id pub-id-type="pmid">23920375</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayhan</surname><given-names>HA</given-names></name><name><surname>Aslan Bayhan</surname><given-names>S</given-names></name><name><surname>Tan&#x00131;k</surname><given-names>N</given-names></name><name><surname>G&#x000fc;rdal</surname><given-names>C</given-names></name></person-group><article-title>The association of spectral-domain optical coherence tomography determined ganglion cell complex parameters and disease severity in Parkinson&#x02019;s disease</article-title><source>Curr Eye Res</source><year>2014</year><volume>39</volume><issue>11</issue><fpage>1117</fpage><lpage>1122</lpage><pub-id pub-id-type="doi">10.3109/02713683.2014.894080</pub-id><?supplied-pmid 24655112?><pub-id pub-id-type="pmid">24655112</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Martin</surname><given-names>E</given-names></name><name><surname>Larrosa</surname><given-names>JM</given-names></name><name><surname>Polo</surname><given-names>V</given-names></name><name><surname>Satue</surname><given-names>M</given-names></name><name><surname>Marques</surname><given-names>ML</given-names></name><name><surname>Alarcia</surname><given-names>R</given-names></name><etal/></person-group><article-title>Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration</article-title><source>Am J Ophthalmol</source><year>2014</year><volume>157</volume><issue>2</issue><fpage>470</fpage><lpage>8. e2</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2013.09.028</pub-id><?supplied-pmid 24315296?><pub-id pub-id-type="pmid">24315296</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunha</surname><given-names>JP</given-names></name><name><surname>Proen&#x000e7;a</surname><given-names>R</given-names></name><name><surname>Dias-Santos</surname><given-names>A</given-names></name><name><surname>Almeida</surname><given-names>R</given-names></name><name><surname>&#x000c1;guas</surname><given-names>H</given-names></name><name><surname>Alves</surname><given-names>M</given-names></name><etal/></person-group><article-title>OCT in Alzheimer&#x02019;s disease: thinning of the RNFL and superior hemiretina</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>2017</year><volume>255</volume><issue>9</issue><fpage>1827</fpage><lpage>1835</lpage><pub-id pub-id-type="doi">10.1007/s00417-017-3715-9</pub-id><?supplied-pmid 28643042?><pub-id pub-id-type="pmid">28643042</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paquet</surname><given-names>C</given-names></name><name><surname>Boissonnot</surname><given-names>M</given-names></name><name><surname>Roger</surname><given-names>F</given-names></name><name><surname>Dighiero</surname><given-names>P</given-names></name><name><surname>Gil</surname><given-names>R</given-names></name><name><surname>Hugon</surname><given-names>J</given-names></name></person-group><article-title>Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer&#x02019;s disease</article-title><source>Neurosci Lett</source><year>2007</year><volume>420</volume><issue>2</issue><fpage>97</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2007.02.090</pub-id><?supplied-pmid 17543991?><pub-id pub-id-type="pmid">17543991</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Thinner changes of the retinal never fiber layer in patients with mild cognitive impairment and Alzheimer&#x02019;s disease</article-title><source>BMC Neurol</source><year>2015</year><volume>1</volume><fpage>14</fpage><pub-id pub-id-type="doi">10.1186/s12883-015-0268-6</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><etal/></person-group><article-title>The utilization of retinal nerve fiber layer thickness to predict cognitive deterioration</article-title><source>J Alzheimers Dis</source><year>2016</year><volume>49</volume><issue>2</issue><fpage>399</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.3233/JAD-150438</pub-id><?supplied-pmid 26484909?><pub-id pub-id-type="pmid">26484909</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trebbastoni</surname><given-names>A</given-names></name><name><surname>D&#x02019;Antonio</surname><given-names>F</given-names></name><name><surname>Bruscolini</surname><given-names>A</given-names></name><name><surname>Marcelli</surname><given-names>M</given-names></name><name><surname>Cecere</surname><given-names>M</given-names></name><name><surname>Campanelli</surname><given-names>A</given-names></name><etal/></person-group><article-title>Retinal nerve fibre layer thickness changes in Alzheimer&#x02019;s disease: results from a 12-month prospective case series</article-title><source>Neurosci Lett</source><year>2016</year><volume>629</volume><fpage>165</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2016.07.006</pub-id><?supplied-pmid 27394689?><pub-id pub-id-type="pmid">27394689</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cronin-Golomb</surname><given-names>A</given-names></name><name><surname>Rizzo</surname><given-names>JF</given-names></name><name><surname>Corkin</surname><given-names>S</given-names></name><name><surname>Growdon</surname><given-names>JH</given-names></name></person-group><article-title>Visual function in Alzheimer's disease and normal aging</article-title><source>Ann NY Acad</source><year>1991</year><volume>640</volume><issue>1</issue><fpage>28</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.1991.tb00186.x</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Justino</surname><given-names>L</given-names></name><name><surname>Kergoat</surname><given-names>M-J</given-names></name><name><surname>Bergman</surname><given-names>H</given-names></name><name><surname>Chertkow</surname><given-names>H</given-names></name><name><surname>Robillard</surname><given-names>A</given-names></name><name><surname>Kergoat</surname><given-names>H</given-names></name></person-group><article-title>Neuroretinal function is normal in early dementia of the Alzheimer type</article-title><source>Neurobiol Aging</source><year>2001</year><volume>22</volume><issue>4</issue><fpage>691</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1016/S0197-4580(01)00234-2</pub-id><?supplied-pmid 11445270?><pub-id pub-id-type="pmid">11445270</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kergoat</surname><given-names>H</given-names></name><name><surname>Kergoat</surname><given-names>MJ</given-names></name><name><surname>Justino</surname><given-names>L</given-names></name><name><surname>Chertkow</surname><given-names>H</given-names></name><name><surname>Robillard</surname><given-names>A</given-names></name><name><surname>Bergman</surname><given-names>H</given-names></name></person-group><article-title>An evaluation of the retinal nerve fiber layer thickness by scanning laser polarimetry in individuals with dementia of the Alzheimer type</article-title><source>Acta Ophthalmol</source><year>2001</year><volume>79</volume><issue>2</issue><fpage>187</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1034/j.1600-0420.2001.079002187.x</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lad</surname><given-names>EM</given-names></name><name><surname>Mukherjee</surname><given-names>D</given-names></name><name><surname>Stinnett</surname><given-names>SS</given-names></name><name><surname>Cousins</surname><given-names>SW</given-names></name><name><surname>Potter</surname><given-names>GG</given-names></name><name><surname>Burke</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer&#x02019;s disease</article-title><source>PLoS One</source><year>2018</year><volume>13</volume><issue>2</issue><fpage>e0192646</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0192646</pub-id><?supplied-pmid 29420642?><pub-id pub-id-type="pmid">29420642</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>CY</given-names></name><name><surname>Ong</surname><given-names>YT</given-names></name><name><surname>Hilal</surname><given-names>S</given-names></name><name><surname>Ikram</surname><given-names>MK</given-names></name><name><surname>Low</surname><given-names>S</given-names></name><name><surname>Ong</surname><given-names>YL</given-names></name><etal/></person-group><article-title>Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer&#x02019;s disease</article-title><source>J Alzheimers Dis</source><year>2015</year><volume>45</volume><issue>1</issue><fpage>45</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.3233/JAD-141659</pub-id><?supplied-pmid 25428254?><pub-id pub-id-type="pmid">25428254</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Martin</surname><given-names>E</given-names></name><name><surname>Bambo</surname><given-names>MP</given-names></name><name><surname>Marques</surname><given-names>ML</given-names></name><name><surname>Satue</surname><given-names>M</given-names></name><name><surname>Otin</surname><given-names>S</given-names></name><name><surname>Larrosa</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer's disease</article-title><source>Acta Ophthalmol</source><year>2016</year><volume>94</volume><issue>6</issue><fpage>e454</fpage><lpage>e4e9</lpage><pub-id pub-id-type="doi">10.1111/aos.12977</pub-id><?supplied-pmid 26895692?><pub-id pub-id-type="pmid">26895692</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>NR</given-names></name></person-group><article-title>Macular ganglion cell -inner plexiform layer thickness is associated with clinical progression in mild cognitive impairment and Alzheimers disease</article-title><source>PloS One</source><year>2016</year><volume>11</volume><issue>9</issue><fpage>e0162202-e</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0162202</pub-id><pub-id pub-id-type="pmid">27598262</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>den Haan</surname><given-names>J</given-names></name><name><surname>Janssen</surname><given-names>SF</given-names></name><name><surname>van de Kreeke</surname><given-names>JA</given-names></name><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>Verbraak</surname><given-names>FD</given-names></name><name><surname>Bouwman</surname><given-names>FH</given-names></name></person-group><article-title>Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer's disease and controls</article-title><source>Alzheimers Dement</source><year>2018</year><volume>10</volume><fpage>49</fpage><lpage>55</lpage></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>CY</given-names></name><name><surname>Johnson</surname><given-names>LN</given-names></name><name><surname>Sinoff</surname><given-names>SE</given-names></name><name><surname>Festa</surname><given-names>EK</given-names></name><name><surname>Heindel</surname><given-names>WC</given-names></name><name><surname>Snyder</surname><given-names>PJ</given-names></name></person-group><article-title>Change in retinal structural anatomy during the preclinical stage of Alzheimer&#x02019;s disease</article-title><source>Alzheimers Dement</source><year>2018</year><volume>10</volume><fpage>196</fpage><lpage>209</lpage></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brewer</surname><given-names>AA</given-names></name><name><surname>Barton</surname><given-names>B</given-names></name></person-group><article-title>Visual cortex in aging and Alzheimer&#x02019;s disease: changes in visual field maps and population receptive fields</article-title><source>Front Psychol</source><year>2014</year><volume>5</volume><fpage>74</fpage><pub-id pub-id-type="doi">10.3389/fpsyg.2014.00074</pub-id><?supplied-pmid 24570669?><pub-id pub-id-type="pmid">24570669</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Lei</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Chu</surname><given-names>WCW</given-names></name><etal/></person-group><article-title>Mapping the &#x0201c;What&#x0201d; and &#x0201c;Where&#x0201d; visual cortices and their atrophy in Alzheimer&#x02019;s disease: Combined activation likelihood estimation with voxel-based morphometry</article-title><source>Front Hum Neurosci</source><year>2016</year><volume>10</volume><fpage>333</fpage><?supplied-pmid 27445770?><pub-id pub-id-type="pmid">27445770</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koronyo-Hamaoui</surname><given-names>M</given-names></name><name><surname>Koronyo</surname><given-names>Y</given-names></name><name><surname>Ljubimov</surname><given-names>AV</given-names></name><name><surname>Miller</surname><given-names>CA</given-names></name><name><surname>Ko</surname><given-names>MK</given-names></name><name><surname>Black</surname><given-names>KL</given-names></name><etal/></person-group><article-title>Identification of amyloid plaques in retinas from Alzheimer&#x02019;s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model</article-title><source>Neuroimage</source><year>2011</year><volume>54</volume><fpage>S204</fpage><lpage>SS17</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.06.020</pub-id><?supplied-pmid 20550967?><pub-id pub-id-type="pmid">20550967</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Morgia</surname><given-names>C</given-names></name><name><surname>Ross-Cisneros</surname><given-names>FN</given-names></name><name><surname>Koronyo</surname><given-names>Y</given-names></name><name><surname>Hannibal</surname><given-names>J</given-names></name><name><surname>Gallassi</surname><given-names>R</given-names></name><name><surname>Cantalupo</surname><given-names>G</given-names></name><etal/></person-group><article-title>Melanopsin retinal ganglion cell loss in Alzheimer disease</article-title><source>Ann Neurol</source><year>2016</year><volume>79</volume><issue>1</issue><fpage>90</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1002/ana.24548</pub-id><?supplied-pmid 26505992?><pub-id pub-id-type="pmid">26505992</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="other">Koronyo Y, Biggs D, Barron E, Boyer DS, Pearlman JA, Au WJ, et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer&#x02019;s disease. JCI Insight. 2017;2(16):e93621.</mixed-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>SE</given-names></name><name><surname>Lumayag</surname><given-names>S</given-names></name><name><surname>Kovacs</surname><given-names>B</given-names></name><name><surname>Mufson</surname><given-names>EJ</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name></person-group><article-title>&#x003b2;-Amyloid deposition and functional impairment in the retina of the APPswe/PS1&#x00394;E9 transgenic mouse model of Alzheimer&#x02019;s disease</article-title><source>Invest Ophthalmol Vis Sci</source><year>2009</year><volume>50</volume><issue>2</issue><fpage>793</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1167/iovs.08-2384</pub-id><?supplied-pmid 18791173?><pub-id pub-id-type="pmid">18791173</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ioshimoto</surname><given-names>GL</given-names></name><name><surname>Nagy</surname><given-names>BV</given-names></name><name><surname>Kremers</surname><given-names>JJ</given-names></name><name><surname>Ventura</surname><given-names>DF</given-names></name></person-group><article-title>ERG changes in a triple transgenic mouse model for Alzheimers disease</article-title><source>Invest Ophthalmol Vis Sci</source><year>2012</year><volume>53</volume><issue>14</issue><fpage>5376</fpage></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antes</surname><given-names>R</given-names></name><name><surname>Ezra-Elia</surname><given-names>R</given-names></name><name><surname>Weinberger</surname><given-names>D</given-names></name><name><surname>Solomon</surname><given-names>A</given-names></name><name><surname>Ofri</surname><given-names>R</given-names></name><name><surname>Michaelson</surname><given-names>DM</given-names></name></person-group><article-title>ApoE4 induces synaptic and ERG impairments in the retina of young targeted replacement apoE4 mice</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>5</issue><fpage>e64949</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0064949</pub-id><?supplied-pmid 23741431?><pub-id pub-id-type="pmid">23741431</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><etal/></person-group><article-title>Subretinal injection of amyloid-&#x003b2; peptide accelerates RPE cell senescence and retinal degeneration</article-title><source>Int J Mol Med</source><year>2015</year><volume>35</volume><issue>1</issue><fpage>169</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.3892/ijmm.2014.1993</pub-id><?supplied-pmid 25385658?><pub-id pub-id-type="pmid">25385658</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>VK</given-names></name><name><surname>Chitranshi</surname><given-names>N</given-names></name><name><surname>Gupta</surname><given-names>VB</given-names></name><name><surname>Golzan</surname><given-names>M</given-names></name><name><surname>Dheer</surname><given-names>Y</given-names></name><name><surname>Vander Wall</surname><given-names>R</given-names></name><etal/></person-group><article-title>Amyloid &#x003b2; accumulation and inner retinal degenerative changes in Alzheimer&#x02019;s disease transgenic mouse</article-title><source>Neurosci Lett</source><year>2016</year><volume>623</volume><fpage>52</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2016.04.059</pub-id><?supplied-pmid 27133194?><pub-id pub-id-type="pmid">27133194</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millar</surname><given-names>JC</given-names></name><name><surname>Webber</surname><given-names>HC</given-names></name><name><surname>Phan</surname><given-names>T</given-names></name><name><surname>Neubauer</surname><given-names>S</given-names></name><name><surname>Clark</surname><given-names>AF</given-names></name></person-group><article-title>Primary open angle glaucoma and Alzheimer&#x02019;s disease: is there an association in 5XFAD mice?</article-title><source>Invest Ophthalmol Vis Sci</source><year>2016</year><volume>57</volume><issue>12</issue><fpage>2543</fpage><pub-id pub-id-type="pmid">27159444</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joly</surname><given-names>Sandrine</given-names></name><name><surname>Lamoureux</surname><given-names>Simon</given-names></name><name><surname>Pernet</surname><given-names>Vincent</given-names></name></person-group><article-title>Nonamyloidogenic processing of amyloid beta precursor protein is associated with retinal function improvement in aging male APP swe /PS1&#x00394;E9 mice</article-title><source>Neurobiology of Aging</source><year>2017</year><volume>53</volume><fpage>181</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.02.004</pub-id><?supplied-pmid 28262325?><pub-id pub-id-type="pmid">28262325</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimazawa</surname><given-names>M</given-names></name><name><surname>Inokuchi</surname><given-names>Y</given-names></name><name><surname>Okuno</surname><given-names>T</given-names></name><name><surname>Nakajima</surname><given-names>Y</given-names></name><name><surname>Sakaguchi</surname><given-names>G</given-names></name><name><surname>Kato</surname><given-names>A</given-names></name><etal/></person-group><article-title>Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling</article-title><source>J Neurochem</source><year>2008</year><volume>107</volume><issue>1</issue><fpage>279</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05606.x</pub-id><?supplied-pmid 18691390?><pub-id pub-id-type="pmid">18691390</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><etal/></person-group><article-title>Neuroprotective effect of memantine on the retinal ganglion cells of APPswe/PS1&#x00394;E9 mice and its immunomodulatory mechanisms</article-title><source>Exp Eye Res</source><year>2015</year><volume>135</volume><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.exer.2015.04.013</pub-id><?supplied-pmid 25912193?><pub-id pub-id-type="pmid">25912193</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leinonen</surname><given-names>H</given-names></name><name><surname>Lipponen</surname><given-names>A</given-names></name><name><surname>Gurevicius</surname><given-names>K</given-names></name><name><surname>Tanila</surname><given-names>H</given-names></name></person-group><article-title>Normal amplitude of electroretinography and visual evoked potential responses in A&#x003b2;PP/PS1 mice</article-title><source>J Alzheimers Dis</source><year>2016</year><volume>51</volume><issue>1</issue><fpage>21</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.3233/JAD-150798</pub-id><?supplied-pmid 26836173?><pub-id pub-id-type="pmid">26836173</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzaro</surname><given-names>N</given-names></name><name><surname>Barini</surname><given-names>E</given-names></name><name><surname>Spillantini</surname><given-names>MG</given-names></name><name><surname>Goedert</surname><given-names>M</given-names></name><name><surname>Medini</surname><given-names>P</given-names></name><name><surname>Gasparini</surname><given-names>L</given-names></name></person-group><article-title>Tau-driven neuronal and neurotrophic dysfunction in a mouse model of early tauopathy</article-title><source>J Neurosci</source><year>2016</year><volume>36</volume><issue>7</issue><fpage>2086</fpage><lpage>2100</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0774-15.2016</pub-id><?supplied-pmid 26888921?><pub-id pub-id-type="pmid">26888921</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Criscuolo</surname><given-names>C</given-names></name><name><surname>Cerri</surname><given-names>E</given-names></name><name><surname>Fabiani</surname><given-names>C</given-names></name><name><surname>Capsoni</surname><given-names>S</given-names></name><name><surname>Cattaneo</surname><given-names>A</given-names></name><name><surname>Domenici</surname><given-names>L</given-names></name></person-group><article-title>The retina as a window to early dysfunctions of Alzheimer&#x02019;s disease following studies with a 5xFAD mouse model</article-title><source>Neurobiol Aging</source><year>2018</year><volume>67</volume><fpage>181</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2018.03.017</pub-id><?supplied-pmid 29735432?><pub-id pub-id-type="pmid">29735432</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiquita</surname><given-names>S</given-names></name><name><surname>Ribeiro</surname><given-names>M</given-names></name><name><surname>Castelhano</surname><given-names>J</given-names></name><name><surname>Oliveira</surname><given-names>F</given-names></name><name><surname>Sereno</surname><given-names>J</given-names></name><name><surname>Batista</surname><given-names>M</given-names></name><etal/></person-group><article-title>A longitudinal multimodal <italic>in vivo</italic> molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss</article-title><source>Hum Mol Genet</source><year>2019</year><volume>28</volume><issue>13</issue><fpage>2174</fpage><lpage>2188</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddz045</pub-id><?supplied-pmid 30816415?><pub-id pub-id-type="pmid">30816415</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oddo</surname><given-names>S</given-names></name><name><surname>Caccamo</surname><given-names>A</given-names></name><name><surname>Kitazawa</surname><given-names>M</given-names></name><name><surname>Tseng</surname><given-names>BP</given-names></name><name><surname>LaFerla</surname><given-names>FM</given-names></name></person-group><article-title>Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer&#x02019;s disease</article-title><source>Neurobiol Aging</source><year>2003</year><volume>24</volume><issue>8</issue><fpage>1063</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2003.08.012</pub-id><?supplied-pmid 14643377?><pub-id pub-id-type="pmid">14643377</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oddo</surname><given-names>S</given-names></name><name><surname>Caccamo</surname><given-names>A</given-names></name><name><surname>Shepherd</surname><given-names>JD</given-names></name><name><surname>Murphy</surname><given-names>MP</given-names></name><name><surname>Golde</surname><given-names>TE</given-names></name><name><surname>Kayed</surname><given-names>R</given-names></name><etal/></person-group><article-title>Triple-transgenic model of Alzheimer&#x02019;s disease with plaques and tangles: intracellular A&#x003b2; and synaptic dysfunction</article-title><source>Neuron.</source><year>2003</year><volume>39</volume><issue>3</issue><fpage>409</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(03)00434-3</pub-id><?supplied-pmid 12895417?><pub-id pub-id-type="pmid">12895417</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawiak</surname><given-names>SJ</given-names></name><name><surname>Wood</surname><given-names>NI</given-names></name><name><surname>Williams</surname><given-names>GB</given-names></name><name><surname>Morton</surname><given-names>AJ</given-names></name><name><surname>Carpenter</surname><given-names>TA</given-names></name></person-group><article-title>Voxel-based morphometry with templates and validation in a mouse model of Huntington&#x02019;s disease</article-title><source>Magn Resonan Imaging</source><year>2013</year><volume>31</volume><issue>9</issue><fpage>1522</fpage><lpage>1531</lpage><pub-id pub-id-type="doi">10.1016/j.mri.2013.06.001</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benchorin</surname><given-names>G</given-names></name><name><surname>Calton</surname><given-names>MA</given-names></name><name><surname>Beaulieu</surname><given-names>MO</given-names></name><name><surname>Vollrath</surname><given-names>D</given-names></name></person-group><article-title>Assessment of murine retinal function by electroretinography</article-title><source>Bio Protoc</source><year>2017</year><volume>7</volume><issue>7</issue><fpage>e2218</fpage><pub-id pub-id-type="doi">10.21769/BioProtoc.2218</pub-id><?supplied-pmid 29177186?><pub-id pub-id-type="pmid">29177186</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>JC</given-names></name><name><surname>Rosario</surname><given-names>ER</given-names></name><name><surname>Kreimer</surname><given-names>S</given-names></name><name><surname>Villamagna</surname><given-names>A</given-names></name><name><surname>Gentzschein</surname><given-names>E</given-names></name><name><surname>Stanczyk</surname><given-names>FZ</given-names></name><etal/></person-group><article-title>Sex differences in &#x003b2;-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure</article-title><source>Brain Res</source><year>2010</year><volume>1366</volume><fpage>233</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2010.10.009</pub-id><?supplied-pmid 20934413?><pub-id pub-id-type="pmid">20934413</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulvey</surname><given-names>B</given-names></name><name><surname>Bhatti</surname><given-names>DL</given-names></name><name><surname>Gyawali</surname><given-names>S</given-names></name><name><surname>Lake</surname><given-names>AM</given-names></name><name><surname>Kriaucionis</surname><given-names>S</given-names></name><name><surname>Ford</surname><given-names>CP</given-names></name><etal/></person-group><article-title>Molecular and functional sex differences of noradrenergic neurons in the mouse locus coeruleus</article-title><source>Cell Rep</source><year>2018</year><volume>23</volume><fpage>2225</fpage><lpage>2235</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.04.054</pub-id><?supplied-pmid 29791834?><pub-id pub-id-type="pmid">29791834</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villa</surname><given-names>A</given-names></name><name><surname>Gelosa</surname><given-names>P</given-names></name><name><surname>Castiglioni</surname><given-names>L</given-names></name><name><surname>Cimino</surname><given-names>M</given-names></name><name><surname>Rizzi</surname><given-names>N</given-names></name><name><surname>Pepe</surname><given-names>G</given-names></name><etal/></person-group><article-title>Sex-specific features of microglia from adult mice</article-title><source>Cell Rep</source><year>2018</year><volume>23</volume><fpage>3501</fpage><lpage>3511</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.05.048</pub-id><?supplied-pmid 29924994?><pub-id pub-id-type="pmid">29924994</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mastrangelo</surname><given-names>MA</given-names></name><name><surname>Bowers</surname><given-names>WJ</given-names></name></person-group><article-title>Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer&#x02019;s disease-related pathologies in male triple-transgenic mice</article-title><source>BMC Neurosci</source><year>2008</year><volume>9</volume><fpage>81</fpage><pub-id pub-id-type="doi">10.1186/1471-2202-9-81</pub-id><?supplied-pmid 18700006?><pub-id pub-id-type="pmid">18700006</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>C</given-names></name><name><surname>Cardoso</surname><given-names>S</given-names></name><name><surname>Correia</surname><given-names>SC</given-names></name><name><surname>Santos</surname><given-names>RX</given-names></name><name><surname>Santos</surname><given-names>MS</given-names></name><name><surname>Baldeiras</surname><given-names>I</given-names></name><etal/></person-group><article-title>Metabolic alterations induced by sucrose intake and Alzheimer&#x02019;s disease promote similar brain mitochondrial abnormalities</article-title><source>Diabetes.</source><year>2012</year><volume>61</volume><fpage>1234</fpage><pub-id pub-id-type="doi">10.2337/db11-1186</pub-id><?supplied-pmid 22427376?><pub-id pub-id-type="pmid">22427376</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>C</given-names></name><name><surname>Machado</surname><given-names>N</given-names></name><name><surname>Mota</surname><given-names>PC</given-names></name><name><surname>Correia</surname><given-names>SC</given-names></name><name><surname>Cardoso</surname><given-names>S</given-names></name><name><surname>Santos</surname><given-names>RX</given-names></name><etal/></person-group><article-title>Type 2 diabetic and Alzheimer&#x02019;s disease mice present similar behavioral, cognitive, and vascular anomalies</article-title><source>J Alzheimers Dis</source><year>2013</year><volume>35</volume><fpage>623</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.3233/JAD-130005</pub-id><?supplied-pmid 23478310?><pub-id pub-id-type="pmid">23478310</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>C</given-names></name><name><surname>Santos</surname><given-names>MS</given-names></name><name><surname>Oliveira</surname><given-names>CR</given-names></name><name><surname>Moreira</surname><given-names>PI</given-names></name></person-group><article-title>Alzheimer&#x02019;s disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers</article-title><source>Biochim Biophys Acta</source><year>2015</year><volume>1852</volume><issue>8</issue><fpage>1665</fpage><lpage>1675</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2015.05.001</pub-id><?supplied-pmid 25960150?><pub-id pub-id-type="pmid">25960150</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kesler</surname><given-names>A</given-names></name><name><surname>Vakhapova</surname><given-names>V</given-names></name><name><surname>Korczyn</surname><given-names>AD</given-names></name><name><surname>Naftaliev</surname><given-names>E</given-names></name><name><surname>Neudorfer</surname><given-names>M</given-names></name></person-group><article-title>Retinal thickness in patients with mild cognitive impairment and Alzheimer&#x02019;s disease</article-title><source>Clin Neurol Neurosurg</source><year>2011</year><volume>113</volume><issue>7</issue><fpage>523</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1016/j.clineuro.2011.02.014</pub-id><?supplied-pmid 21454010?><pub-id pub-id-type="pmid">21454010</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>KL</given-names></name><name><surname>Yeo</surname><given-names>JM</given-names></name><name><surname>Waddell</surname><given-names>B</given-names></name><name><surname>Cameron</surname><given-names>JR</given-names></name><name><surname>Pal</surname><given-names>S</given-names></name></person-group><article-title>A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography</article-title><source>Alzheimers Dement</source><year>2015</year><volume>1</volume><issue>2</issue><fpage>136</fpage><lpage>143</lpage></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laguna</surname><given-names>A</given-names></name><name><surname>Barallobre</surname><given-names>M-J</given-names></name><name><surname>Marchena</surname><given-names>M-&#x000c1;</given-names></name><name><surname>Mateus</surname><given-names>C</given-names></name><name><surname>Ram&#x000ed;rez</surname><given-names>E</given-names></name><name><surname>Mart&#x000ed;nez-Cue</surname><given-names>C</given-names></name><etal/></person-group><article-title>Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome</article-title><source>Hum Mol Genet</source><year>2013</year><volume>22</volume><issue>14</issue><fpage>2775</fpage><lpage>2784</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddt125</pub-id><?supplied-pmid 23512985?><pub-id pub-id-type="pmid">23512985</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyure</surname><given-names>KA</given-names></name><name><surname>Durham</surname><given-names>R</given-names></name><name><surname>Stewart</surname><given-names>WF</given-names></name><name><surname>Smialek</surname><given-names>JE</given-names></name><name><surname>Troncoso</surname><given-names>JC</given-names></name></person-group><article-title>Intraneuronal A&#x003b2;-amyloid precedes development of amyloid plaques in Down syndrome</article-title><source>Arch Pathol Lab Med</source><year>2001</year><volume>125</volume><issue>4</issue><fpage>489</fpage><lpage>492</lpage><?supplied-pmid 11260621?><pub-id pub-id-type="pmid">11260621</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Selkoe</surname><given-names>DJ</given-names></name></person-group><article-title>The amyloid hypothesis of Alzheimer&#x02019;s disease: progress and problems on the road to therapeutics</article-title><source>Science</source><year>2002</year><volume>297</volume><issue>5580</issue><fpage>353</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1126/science.1072994</pub-id><?supplied-pmid 12130773?><pub-id pub-id-type="pmid">12130773</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Mucke</surname><given-names>L</given-names></name></person-group><article-title>Alzheimer mechanisms and therapeutic strategies</article-title><source>Cell</source><year>2012</year><volume>148</volume><issue>6</issue><fpage>1204</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.02.040</pub-id><?supplied-pmid 22424230?><pub-id pub-id-type="pmid">22424230</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>B</given-names></name><name><surname>Rimmer</surname><given-names>S</given-names></name><name><surname>Iragui</surname><given-names>V</given-names></name><name><surname>Katzman</surname><given-names>R</given-names></name></person-group><article-title>Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration?</article-title><source>Ann Neurol</source><year>1989</year><volume>26</volume><issue>2</issue><fpage>221</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1002/ana.410260207</pub-id><?supplied-pmid 2774509?><pub-id pub-id-type="pmid">2774509</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nesher</surname><given-names>R</given-names></name><name><surname>Trick</surname><given-names>GL</given-names></name></person-group><article-title>The pattern electroretinogram in retinal and optic nerve disease</article-title><source>Doc Ophthalmol</source><year>1991</year><volume>77</volume><issue>3</issue><fpage>225</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1007/BF00161370</pub-id><?supplied-pmid 1760971?><pub-id pub-id-type="pmid">1760971</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krasodomska</surname><given-names>K</given-names></name><name><surname>Lubi&#x00144;ski</surname><given-names>W</given-names></name><name><surname>Potemkowski</surname><given-names>A</given-names></name><name><surname>Honczarenko</surname><given-names>K</given-names></name></person-group><article-title>Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer&#x02019;s disease</article-title><source>Doc Ophthalmol</source><year>2010</year><volume>121</volume><issue>2</issue><fpage>111</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1007/s10633-010-9238-x</pub-id><?supplied-pmid 20549299?><pub-id pub-id-type="pmid">20549299</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sartucci</surname><given-names>F</given-names></name><name><surname>Borghetti</surname><given-names>D</given-names></name><name><surname>Bocci</surname><given-names>T</given-names></name><name><surname>Murri</surname><given-names>L</given-names></name><name><surname>Orsini</surname><given-names>P</given-names></name><name><surname>Porciatti</surname><given-names>V</given-names></name><etal/></person-group><article-title>Dysfunction of the magnocellular stream in Alzheimer&#x02019;s disease evaluated by pattern electroretinograms and visual evoked potentials</article-title><source>Brain Res Bull</source><year>2010</year><volume>82</volume><issue>3</issue><fpage>169</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/j.brainresbull.2010.04.001</pub-id><?supplied-pmid 20385208?><pub-id pub-id-type="pmid">20385208</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="other">Strenn K, Dal-Bianco P, Weghaupt H, Koch G, Vass C, Gottlob I. Pattern electroretinogram and luminance electroretinogram in Alzheimer&#x02019;s disease. J Neural Transm Suppl.&#x000a0;1991;33:73&#x02013;80.</mixed-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prager</surname><given-names>TC</given-names></name><name><surname>Schweitzer</surname><given-names>FC</given-names></name><name><surname>Peacock</surname><given-names>LW</given-names></name><name><surname>Garcia</surname><given-names>CA</given-names></name></person-group><article-title>The effect of optical defocus on the pattern electroretinogram in normal subjects and patients with Alzheimer&#x02019;s disease</article-title><source>Am J Ophthalmol</source><year>1993</year><volume>116</volume><issue>3</issue><fpage>363</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1016/S0002-9394(14)71355-8</pub-id><?supplied-pmid 8357062?><pub-id pub-id-type="pmid">8357062</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>MH</given-names></name><name><surname>Ivers</surname><given-names>KM</given-names></name><name><surname>Frishman</surname><given-names>LJ</given-names></name></person-group><article-title>Retinal pathway origins of the pattern ERG of the mouse</article-title><source>Exp Eye Res</source><year>2009</year><volume>89</volume><issue>1</issue><fpage>49</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.exer.2009.02.009</pub-id><?supplied-pmid 19250935?><pub-id pub-id-type="pmid">19250935</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiasseu</surname><given-names>M</given-names></name><name><surname>Alarcon-Martinez</surname><given-names>L</given-names></name><name><surname>Belforte</surname><given-names>N</given-names></name><name><surname>Quintero</surname><given-names>H</given-names></name><name><surname>Dotigny</surname><given-names>F</given-names></name><name><surname>Destroismaisons</surname><given-names>L</given-names></name><etal/></person-group><article-title>Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer&#x02019;s disease</article-title><source>Mol Neurodegener</source><year>2017</year><volume>12</volume><issue>1</issue><fpage>58</fpage><pub-id pub-id-type="doi">10.1186/s13024-017-0199-3</pub-id><?supplied-pmid 28774322?><pub-id pub-id-type="pmid">28774322</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimaldi</surname><given-names>A</given-names></name><name><surname>Brighi</surname><given-names>C</given-names></name><name><surname>Peruzzi</surname><given-names>G</given-names></name><name><surname>Ragozzino</surname><given-names>D</given-names></name><name><surname>Bonanni</surname><given-names>V</given-names></name><name><surname>Limatola</surname><given-names>C</given-names></name><etal/></person-group><article-title>Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer&#x02019;s disease in the 3xTg-AD mouse model</article-title><source>Cell Death Dis</source><year>2018</year><volume>9</volume><issue>6</issue><fpage>685</fpage><pub-id pub-id-type="doi">10.1038/s41419-018-0740-5</pub-id><?supplied-pmid 29880901?><pub-id pub-id-type="pmid">29880901</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Jin</surname><given-names>N</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Alzheimer&#x02019;s disease is responsible for progressive age-dependent differential expression of various protein cascades in retina of mice</article-title><source>ACS Chem Neurosci</source><year>2019</year><volume>10</volume><issue>5</issue><fpage>2418</fpage><lpage>2433</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.8b00710</pub-id><?supplied-pmid 30695639?><pub-id pub-id-type="pmid">30695639</pub-id></element-citation></ref></ref-list></back></article>